Top 12 Trusted Private Label PDRN Skincare Manufacturers in China 2026

Rank	Manufacturer	City	Key Strength	Best For
1	Metro Private Label	Guangzhou	Flexible PDRN formulation, packaging coordination, manageable MOQ, export documentation	E-commerce brands, beauty founders, clinics, growing skincare brands
2	TY Cosmetic	Guangzhou	Large-scale OEM/ODM capacity, broad beauty categories, strong production infrastructure	Established brands, distributors, multi-category beauty businesses
3	Baiyur Beauty	Guangzhou	Ready-to-launch PDRN range, low-MOQ private label, fast commercialization	Small brands, Amazon sellers, distributors, salons
4	Viansh Wellness	Shanghai	PDRN, barrier-repair and post-procedure skincare specialization	Aesthetic clinics, medspas, professional skincare brands
5	XJ Beauty	Shanghai / Wenzhou	Turnkey product development, trend research, formulation and packaging integration	DTC brands, established beauty brands, trend-led product teams
6	Yangge Biotech	Xi’an	Upstream PDRN raw material supply, COA and ingredient specification support	Cosmetic factories, laboratories, brands sourcing PDRN ingredients
7	Shiruoni	Guangzhou	Broad PDRN product formats, turnkey OEM/ODM, export documentation	E-commerce brands, distributors, multi-SKU private label projects
8	Xiran Skincare	Guangzhou	Wide PDRN catalog, flexible MOQ, fast private-label development	Amazon, Shopify and TikTok brands, distributors, emerging brands
9	Desifine	Guangzhou	Functional skincare R&D, PDRN stabilization positioning, mature OEM/ODM system	Established brands, technical beauty founders, premium skincare projects
10	Aisen Pro Skin	Guangzhou	Active-led R&D, peptide and PDRN combinations, scalable manufacturing	Growing brands, clinics, anti-aging and skin-longevity brands
11	Blackbird Skincare	Foshan	Private-label sourcing, packaging and supply-chain coordination	Startups, e-commerce sellers, buyers wanting one-stop sourcing
12	Dr. Rashel BBG	Yiwu / Guangzhou	Large product range, export network, high-volume OEM coordination	Distributors, wholesalers, regional retailers, channel-driven buyers

Finding a PDRN skincare manufacturer in China is easy; deciding which supplier is actually worth contacting is much harder. Many companies now offer PDRN serums, creams, masks, eye products, and toner pads, but the real differences are found in PDRN raw-material quality, formulation capability, MOQ, packaging support, documentation, production scale, and how well the supplier fits the project.

In this guide, I compare 12 private label PDRN skincare manufacturers in China based on their visible PDRN capabilities, OEM/ODM support, manufacturing structure, quality systems, customization options, and commercial fit. I also distinguish between direct manufacturers, trading companies, and upstream ingredient suppliers, because they do not provide the same level of service.

My goal is not to claim that one company is the best for every buyer. It is to make the differences clear enough that you can quickly identify which manufacturers deserve a place on your shortlist before requesting samples, quotations, and technical documents.

How We Selected the 12 PDRN Skincare Manufacturers

When I use the word “trusted” in this article, I am not suggesting that a manufacturer should be considered reliable simply because it appears on Google, ranks well for PDRN-related keywords, or presents an impressive website. In a fast-growing category like PDRN skincare, it has become increasingly common for suppliers to add trending ingredients to product pages very quickly, so the real challenge for buyers is not finding names but identifying which companies show enough evidence of genuine manufacturing capability. For this comparison, I looked at the manufacturers from the perspective of someone preparing to shortlist suppliers for a real commercial project. That means paying attention to whether the company shows meaningful PDRN product development, whether it can handle private label and OEM/ODM projects beyond basic relabeling, what manufacturing and quality systems are visible, whether its MOQ matches realistic order sizes, how much documentation and export support it can provide, and which types of buyers it is best positioned to serve. This matters because the most useful sourcing question is rarely “Which company looks the biggest?” or “Which one appears first in search results?” The more practical question is whether the manufacturer has the right combination of formulation capability, production flexibility, documentation, packaging support, communication, and scale for the buyer’s actual project.

Evidence of PDRN Product Development

The first thing I looked for was evidence that PDRN is part of the manufacturer’s real product-development activity rather than simply a keyword added to a blog article or a generic serum page. A company that publicly shows several PDRN formats, such as serums, creams, eye products, toner pads, masks, ampoules, or treatment products, gives me more confidence that its formulation team has worked with the ingredient across different textures, product systems, and positioning concepts. I also pay attention to whether the manufacturer discusses supporting actives, concentration options, texture direction, raw-material sourcing, ingredient combinations, preservation, or customization instead of relying only on broad marketing phrases such as anti-aging, repair, or rejuvenation. None of these signals alone can prove that one factory has a technically better PDRN formula than another, but together they provide a much stronger indication that the supplier is actively developing commercial PDRN skincare rather than simply reacting to a trend. For buyers, this distinction is important because a manufacturer that understands how PDRN behaves within different formulation systems is usually better prepared to discuss realistic concentration, stability, supporting ingredients, packaging compatibility, and how the product should be positioned for a specific market.

Private Label and OEM ODM Capability

Another major part of the screening process was understanding how far each manufacturer can actually take a project, because private label, OEM, and ODM are often used very broadly in the skincare industry and do not always describe the same level of service. Some buyers only need a mature PDRN formula filled into standard packaging with their own label and carton, while others want to modify the active combination, texture, viscosity, fragrance, preservative approach, packaging format, or even the entire formula architecture. For that reason, I looked at whether each manufacturer appears capable of supporting ready formulas, semi-custom development, full custom formulation, bulk production, filling, bottle and pump sourcing, label application, carton production, and export preparation as part of one coordinated process. This is more important than it may seem because different buyers need very different levels of development support. A distributor or e-commerce operator may value speed and prefer a proven formula that can be branded quickly, while an experienced skincare founder may want several sample rounds and expect the factory to explain why a certain ingredient combination, texture, or packaging decision makes more technical and commercial sense. A manufacturer does not need to offer every possible service to be a good supplier, but the level of support should match the type of project the buyer is trying to build.

Manufacturing and Quality Systems

Manufacturing credibility is another area where I prefer to look beyond a single certificate or a photograph of a production line. ISO 22716 and GMPC are useful signals because they indicate that a company operates within recognized cosmetic manufacturing frameworks, but the real value lies in the quality system that supports day-to-day production. I therefore consider whether the manufacturer provides visible information about controlled production environments, cleanroom management, raw-material inspection, batch records, microbiological control, finished-product testing, stability evaluation, traceability, and quality-control procedures. From a buyer’s perspective, the question is not only whether the factory can make one attractive sample; the more important issue is whether the same formula, color, viscosity, fragrance, filling volume, and overall product quality can be reproduced consistently when the project moves from a small development batch to 1,000, 10,000, or even 100,000 finished units. This becomes especially relevant with PDRN products because premium active ingredients, preservation systems, pH, packaging compatibility, storage conditions, and raw-material handling can all affect the final result. A large factory is not automatically better, but a manufacturer that can demonstrate a structured quality and traceability system generally gives international buyers more confidence than one that relies mainly on product claims and production-capacity figures.

MOQ and Production Scale

MOQ is one of the areas where many manufacturer comparisons become too simplistic because the lowest MOQ is not always the best option, and the largest factory is not automatically the best partner. A manufacturer designed around very large production programs may have excellent automation, procurement power, and capacity, but it may not be flexible enough for an e-commerce brand that wants to test 1,000 bottles of a new PDRN serum before committing to a larger rollout. On the other hand, a smaller or more flexible manufacturer that is comfortable with 1,000 to 3,000 units may be ideal for emerging brands but less suitable for a multinational buyer that requires much larger annual volumes, formal audit procedures, multiple production sites, and rigid supply-chain systems. I also pay close attention to the difference between formula MOQ and packaging MOQ, because this is one of the most common sources of misunderstanding during private label projects. A factory may be willing to produce 1,000 units of the formula, while a custom bottle, pump, printed carton, silk-screen decoration, hot stamping, or molded component may require 3,000, 5,000, or even more units from the packaging supplier. This is why production scale should always be considered together with the buyer’s business model, launch plan, packaging expectations, and expected repeat-order volume rather than treated as a single number on a quotation sheet.

Documentation and Export Support

Documentation is one of the clearest indicators of whether a manufacturer is prepared to support international customers rather than only domestic or very simple private label projects. A good formula can still create problems if the buyer cannot obtain the technical information required for product registration, customs, platform review, label preparation, or local regulatory assessment, so I look at whether the manufacturer can provide documents such as the full INCI list, raw-material or finished-product COA, SDS or MSDS, product specifications, microbiological or stability-related testing information, and the documents normally required for export. It is also useful to see whether the company has visible experience serving markets such as the European Union, the United Kingdom, the United States, Canada, or other regulated destinations because these customers usually ask more detailed questions about claims, labels, ingredients, and supporting files. I do not expect the factory to replace the legal responsibilities of the brand owner, responsible person, or local compliance consultant, but I do expect the manufacturer to provide accurate and usable technical information that can support that process. This becomes particularly important with PDRN because buyers may need to verify the exact ingredient identity, source, supplier specification, addition level, raw-material documentation, and how the ingredient is represented on the INCI before they can make responsible decisions about product positioning and market claims.

Fit With Different Buyer Types

The final part of the screening process was deciding which type of buyer each manufacturer is most suitable for, because I do not believe there is one PDRN skincare factory that is objectively “best” for every project. An Amazon or Shopify operator usually values fast sampling, manageable MOQ, packaging coordination, clear lead times, and reliable replenishment because delays can directly affect product launches, inventory, reviews, and ranking. An experienced beauty-industry founder may care more about formulation logic, skin feel, ingredient combinations, texture refinement, long-term product differentiation, and whether the factory can help expand one successful hero product into a broader skincare range. A distributor or retail buyer often prefers mature ready-to-label formulas, fast quotation, multiple SKU options, predictable pricing, and stable supply because the priority is getting products into an existing sales channel with controlled risk. A clinic or aesthetic business may focus more heavily on mild formulations, professional positioning, documentation, treatment compatibility, and products that can support repeat purchase after in-clinic services, while larger established brands are more likely to prioritize audits, traceability, production capacity, supplier governance, and long-term consistency. Looking at each manufacturer through these different business models makes the ranking much more useful because it reflects how sourcing decisions are actually made in the market rather than pretending that every buyer has the same budget, order quantity, level of technical knowledge, or commercial objective.

What Is Really Happening Behind the Search for PDRN Manufacturers

When I look at why buyers are searching for PDRN manufacturers now, the issue is not that the market lacks suppliers. In fact, the opposite is happening. As PDRN has become more visible in anti-aging, repair, post-treatment, and premium skincare positioning, more factories have started presenting PDRN serums, salmon DNA serums, PDRN collagen creams, jelly masks, eye products, and other related concepts. From the outside, this creates the impression that buyers have more choice than ever, but in practice it also makes supplier evaluation more difficult. A product page can tell me that a factory offers “PDRN skincare,” but it does not automatically tell me what raw material is being used, how that material is specified, what the quoted percentage actually represents, whether the formula has been properly developed around the ingredient, what documentation is available, or whether the finished product is suitable for the buyer’s target market. This is the real sourcing problem behind searches such as “Top,” “Trusted,” “Manufacturers,” and “China.” Buyers are not struggling to find names; they are struggling to separate marketing claims from information that can actually support a purchasing decision.

PDRN Has Become Easier to Market Than to Verify

One of the biggest changes I see in the market is that PDRN has become much easier to promote than to technically compare. A factory can place terms such as “PDRN serum,” “salmon DNA repair serum,” or “PDRN collagen cream” on a website very quickly, but those names alone do not tell a buyer enough about the underlying formulation. Two suppliers may both advertise a “1% PDRN serum,” yet the actual raw materials behind those percentages may be very different in concentration, carrier system, supplier specification, or recommended usage level. One percentage may refer to the amount of a premixed raw-material solution added to the formula, while another may refer to a different specification entirely, which means a buyer cannot assume that the higher number automatically represents a stronger or more valuable product. This is why I do not think PDRN products should be compared only by headline concentration or product name. The more important questions are what ingredient is actually being used, what documentation supports it, how it is incorporated into the formula, and whether the manufacturer can explain those details clearly enough for the buyer to understand what they are paying for.

The Formula Matters More Than the PDRN Name on the Label

Another issue is that PDRN does not work in isolation from the rest of the formula. A manufacturer may use an attractive active ingredient, but the final product still depends on the surrounding formulation system, including pH, humectants, thickeners, emulsifiers, supporting actives, preservation, packaging, and storage conditions. From a sourcing perspective, this matters because a product can look impressive on a quotation sheet and still create problems later if the texture changes, the preservative system is not robust enough, the packaging does not dispense the formula properly, or the formula does not remain stable under realistic shipping and storage conditions. I pay particular attention to preservation because buyers increasingly request “clean,” phenoxyethanol-free, or more minimalist systems, yet removing a familiar preservative does not automatically improve the finished product. The manufacturer still needs to ensure that the formula remains microbiologically safe and stable over its intended shelf life. This is where real formulation capability becomes more important than simply having PDRN in the ingredient list.

Documentation Is Often Where Supplier Differences Become Clear

The gap between suppliers also becomes much more visible when the buyer starts asking for documents rather than marketing materials. A serious project may require the INCI list, raw-material COA, SDS or MSDS, product specifications, testing information, batch-related records, export documents, or supporting data that can be used for compliance and label preparation. In my experience, this is often the stage where two manufacturers that looked almost identical at first begin to separate very quickly. One may be able to provide clear ingredient information, explain the PDRN source and specification, and support the buyer with usable technical files, while another may only provide a finished-product ingredient list or broad marketing statements. For international buyers, this difference matters because a product is not truly launch-ready simply because the sample looks good. The brand still needs to understand what it is selling, how it should be labeled, what claims are realistic, and what information may be required by its destination market or sales platform.

The Real Search Intent Is Supplier Verification, Not Supplier Discovery

This is why I interpret searches for “Top PDRN Manufacturers in China” differently from a basic supplier search. The buyer can already find hundreds of names through Google, Alibaba, Made-in-China, Global Sources, and other sourcing channels, so discovery itself is no longer the main problem. What the buyer really needs is a way to compare suppliers on the same basis and reduce the risk of choosing the wrong one. They want to know which manufacturers show real PDRN development capability, which ones can support custom formulas, which ones have suitable MOQ, which ones understand export documentation, which ones are better for e-commerce brands or clinics, and which ones are designed for much larger production programs. That is the industry reality behind words such as “Top,” “Trusted,” “Manufacturers,” and “China.” The searcher is not asking Google to give them more supplier names; they are asking Google to help them decide which suppliers deserve to enter the next stage of sourcing.

Buyers Are Short of Comparable Information, Not Supplier Options

For me, this is the most important point behind the entire article. The PDRN market does not have a shortage of suppliers; it has a shortage of information that is comparable, specific, and verifiable enough to support a commercial decision. Buyers often receive quotations that use different terminology, different concentration logic, different packaging assumptions, different included documents, and different testing standards, which makes side-by-side comparison difficult even when the unit prices appear simple. A cheaper quotation may exclude packaging development or testing, while a higher quotation may include more complete documentation and project support. One supplier may be ideal for a 1,000-unit test launch, while another may only become commercially attractive at 10,000 or 50,000 units. This is why I believe a useful manufacturer comparison should go beyond company introductions and help the reader understand what needs to be verified before they request samples or place an order. The real value is not in telling buyers that twelve factories exist; it is in helping them understand what makes those twelve factories meaningfully different.

A Real PDRN Development Case Why 1 Percent PDRN Was Not Enough to Start Production

One of the clearest ways I can explain the difference between a simple PDRN product inquiry and a real manufacturing project is through an anonymized case from a North American skincare brand we worked with. The buyer already had a clear product direction and did not come to us asking what PDRN was or whether the ingredient was popular. They wanted a premium PDRN serum positioned for sensitive skin, with a 1% Sodium DNA target, no fragrance, no phenoxyethanol, premium packaging, and the intention to sell into international markets. On paper, this looked like a straightforward brief, and the initial question could easily have been reduced to “Can you manufacture a 1% PDRN serum?” In practice, that question opened several technical and commercial decisions before we could responsibly move toward production. We had to clarify what the 1% actually referred to, how the raw material was specified, how the preservative system would work without phenoxyethanol, whether the packaging was suitable for the finished viscosity and formula, what testing would be required, and whether the product positioning could be supported in the buyer’s target markets. This is exactly why I do not evaluate PDRN manufacturers only by whether they say “yes” to a concentration request. The real value of a manufacturer appears in the questions it asks before saying yes.

The Buyer’s Original Request

The buyer approached us with a brief that was already more detailed than a typical first-time private label inquiry. They wanted a premium PDRN serum with a 1% Sodium DNA target, sensitive-skin-friendly positioning, no added fragrance, no phenoxyethanol, and packaging that would support a higher-end biotech skincare image. They were also thinking beyond a single local market, which meant the finished formula and documentation would eventually need to make sense for international commercialization rather than only for domestic sale. From a sales perspective, this type of project can look easy because the buyer already knows the hero ingredient, product format, claims direction, and packaging level. From a formulation perspective, however, those requirements are interconnected. A change made to satisfy the “cleaner” preservative positioning can affect shelf-life strategy, a change in active loading can affect the formula system, and a premium airless package can become unsuitable if the finished viscosity does not match the pump mechanism. That is why our first task was not to quote a bottle of “1% PDRN serum” as quickly as possible. It was to make sure the specification actually meant the same thing to the buyer, the raw-material supplier, the formulation team, and the eventual finished-product documentation.

The First Problem Was What 1 Percent Actually Meant

The first technical issue was the number itself. In PDRN sourcing, “1%” can look very precise while still being ambiguous if the buyer and manufacturer are not referring to the same raw-material basis. Before treating 1% as a meaningful specification, we needed to clarify the exact ingredient being proposed, its INCI name, the supplier specification, the concentration of the supplied raw material, the recommended addition range, relevant molecular characteristics, and the supporting COA documentation. This matters because manufacturers may purchase PDRN-related materials in different forms and at different specifications, so the amount added to a finished formula is not always the same as the amount of active material a buyer imagines when reading a percentage on a quotation. A buyer could therefore compare one factory offering “0.5% PDRN” with another offering “1% PDRN” and assume the second product contains twice as much meaningful active, even though the two suppliers may be using raw materials with completely different concentration bases or specifications. I see this as one of the most important sourcing lessons in the PDRN category: percentages should only be compared after the underlying raw material has been identified. Without the INCI, specification, COA, source, and concentration logic, the number alone is more useful for marketing than for technical comparison.

Removing Phenoxyethanol Created a Second Formulation Decision

The next challenge came from the buyer’s request to remove phenoxyethanol. I understand why brands make this request, particularly when they are building a sensitive-skin, premium, or “cleaner formulation” story, but removing one preservative is not the same as improving the safety or quality of the finished product. Once phenoxyethanol was excluded, the formulation discussion had to shift toward the performance of the entire preservative system and how that system would interact with the rest of the serum. We had to consider microbial protection, skin tolerance, compatibility with the PDRN-related material, pH, supporting ingredients, intended shelf life, and whether the system could ultimately pass appropriate challenge testing. The important question was no longer “Can we make this phenoxyethanol-free?” because technically that is often possible. The more responsible question became “Can we maintain microbiological stability, acceptable skin feel, and the intended shelf-life performance while still supporting the brand positioning?” This is where I think buyers can quickly distinguish between a factory that simply replaces one preservative to satisfy a marketing request and a formulation team that treats preservation as part of the complete product system. For an international skincare project, especially one positioned for sensitive skin, I would rather spend more time resolving this question before launch than discover after production that the product’s preservation strategy was designed around a claim rather than around actual stability.

Packaging Became Part of Formula Development

The packaging discussion also became more technical than simply choosing the most attractive bottle. The buyer wanted a premium presentation, but the package still had to function with the finished serum, which meant we needed to consider viscosity, pump output, air exposure, dosage consistency, component compatibility, filling behavior, and the overall user experience. A bottle that looks ideal in a rendering can perform poorly if the serum is too thick for the pump, if the dispensing volume is inconsistent, or if the formula interacts unfavorably with a component during storage. This is why I do not treat packaging as a separate step that begins only after the formula is complete. In many projects, formula and packaging need to be evaluated together because one can change the suitability of the other. PDRN development is therefore not simply a matter of combining a fashionable raw material with a premium bottle. The commercial product is the result of the raw-material specification, formulation system, preservation strategy, packaging compatibility, testing plan, and regulatory positioning working together. A manufacturer that understands this will often slow the project down slightly at the evaluation stage, but that extra discipline can prevent much more expensive problems during bulk production or after the product reaches the market.

What This Case Teaches Buyers

What I took from this project is that a capable PDRN manufacturer should not treat every detailed brief as an instruction sheet that only requires a quick “yes.” In many cases, the quality of the supplier can be judged by the questions that come back before sampling begins. Which PDRN material are we talking about? What is the supplier specification? What does the requested percentage represent in the finished formula? Which market will the product enter? What claims is the brand planning to make? Which preservatives are acceptable or excluded? What packaging format is being considered? What testing level is expected? What shelf-life target needs to be supported? These questions may make the early discussion longer, but they also show whether the manufacturer is thinking about the product as something that must survive formulation, production, shipping, compliance review, and real consumer use rather than as a sample created only to win an order. For buyers comparing Chinese PDRN manufacturers, this is the practical lesson I would keep in mind: the best supplier is not always the one that agrees fastest. Very often, it is the one that understands where the project can fail and raises those issues before the buyer has committed to bulk production.

Top 12 Private Label PDRN Skincare Manufacturers in China 2026

Metro Private Label

We are Metro Private Label, the international business division of Guangzhou Baiyanhui Cosmetics Co., Ltd., a Guangzhou-based skincare manufacturer serving private-label and custom-development projects for overseas brands. Our role is not limited to filling an existing formula into a bottle; the way we work is closer to connecting formulation, packaging, documentation, production, and repeat-order consistency into one development process. This is especially relevant for PDRN skincare because buyers rarely come to us with only one requirement. They usually need to balance ingredient positioning, target concentration, skin feel, packaging, MOQ, compliance expectations, and launch timing at the same time. Our current manufacturing system supports both smaller testing programs and larger scale-up projects, with two integrated factory buildings, more than ten in-house R&D engineers, 30 kg to 1,000 kg batch capacity, four assembly lines, dedicated packaging sanitization, semi- and fully automated filling systems, and separated storage for raw materials, packaging, and finished products. The company also operates under a GMPC-certified manufacturing system, which is important for brands that need a supplier capable of supporting repeat production rather than a one-off private-label order.

PDRN Skincare Capability

Our PDRN capability is built around developing a broader product system rather than treating PDRN as a single serum trend. The current range includes PDRN repair serums, post-treatment cooling gels, barrier repair creams, hydrogel masks, eye recovery products, topical booster ampoules, targeted spot gels, and overnight recovery masks, which allows a brand to begin with one hero SKU and later build a more complete PDRN-focused routine. In formulation discussions, we typically look beyond the PDRN name itself and consider how the raw material fits with supporting actives such as peptides, ceramides, niacinamide, panthenol, hyaluronic acid, CICA, beta-glucan, or squalane depending on the positioning the buyer wants to create. Our current PDRN program supports both Sodium DNA-based concepts and cosmetic PDRN-related options, but in practice the important part is not simply selecting one ingredient label; we need to confirm the raw-material specification, intended addition level, target market, formula system, preservation strategy, and final claims direction before the product can be developed responsibly. This is also why we offer different development paths, from ready-to-brand formulas for faster market entry to semi-custom and more deeply customized projects where texture, active combinations, packaging, and product positioning can be adjusted around the brand’s commercial needs.

Manufacturing Strength

The part of our manufacturing system that matters most to PDRN projects is not simply factory size but the ability to move a formula from laboratory development into repeatable commercial production. We document formula standards, raw materials, packaging compatibility, and production requirements so that a product can remain consistent from the first sample through later reorders. Packaging is evaluated together with the formula because viscosity, pump output, air exposure, leakage risk, and material compatibility can affect the finished product just as much as the ingredient story. For brands testing the market, our current PDRN program can use stock packaging from roughly 500 to 800 units in some product formats, while fully customized packaging may move into the 5,000-unit range; hydrogel masks follow a different production structure, with standard commercial quantities typically calculated by box and total mask count. We also support technical and export documentation such as INCI, COA, SDS, product specifications, stability and compatibility information, and related compliance preparation, which becomes especially important when a buyer plans to sell in markets such as the United States, European Union, United Kingdom, Canada, or the Middle East. What I consider more important than quoting the lowest possible MOQ is making sure the formula MOQ, packaging MOQ, testing requirements, and expected scale all make commercial sense together before the buyer commits to production.

Best For

I would place Metro Private Label most strongly in the category of manufacturers suited to growing skincare brands that already have a clear sales channel or product direction but still need practical development support from the factory. This includes Amazon and Shopify operators launching or extending a PDRN hero product, beauty-industry founders who understand ingredients and positioning but need a stable manufacturing partner, aesthetic clinics that want to turn professional skincare concepts into a retail line, and distributors that need a supplier capable of supporting several PDRN formats under one brand. The strongest fit is usually a buyer who values a manageable starting quantity, clear formulation communication, packaging coordination, international documentation, and the ability to move from one SKU into a larger product system as sales develop. A very large multinational procurement program built around extremely high annual volumes, formal global tenders, or rigid multi-site sourcing procedures may be better suited to a much larger industrial manufacturer, but for brands that need a more flexible balance between R&D communication, production scale, customization, and commercial execution, that is the area where I believe our manufacturing model is most relevant.

TY Cosmetic

TY Cosmetic is a Guangzhou-based OEM/ODM beauty manufacturer with a much broader product scope than a specialist skincare-only factory. From its current website, the company develops and manufactures skincare, sunscreen, hair care, color cosmetics, men’s grooming, body care, and several other personal-care categories, which tells me that its main competitive position is manufacturing breadth and one-stop project execution rather than specialization in a single active ingredient. TY reports more than 11,900 formulations developed, approximately 67,500 square meters of combined production area, daily emulsification capacity of 150 tons, more than 1,985 brand clients served, and exports to over 31 countries. As another manufacturer working in the Guangzhou cosmetics supply chain, I see this type of scale as particularly relevant for buyers that want to consolidate several categories with one supplier instead of sourcing serum, cream, sunscreen, and other products from separate factories. Its headquarters and laboratories are located in Guangzhou’s Baiyun District, and the company presents its service model around formulation development, packaging coordination, compliant production, sampling, and long-term scale-up rather than simple finished-formula relabeling.

PDRN Skincare Capability

I would be more careful when describing TY Cosmetic specifically as a PDRN manufacturer. At the time of this review, I could not find a dedicated PDRN category, PDRN product page, or clearly indexed PDRN formulation on its official website, even though the company publicly shows extensive face-care capabilities covering serums, creams, toners, masks, cleansers, eye care, and complete skincare lines. That does not necessarily mean TY cannot develop a PDRN serum or cream; its OEM/ODM model explicitly supports formula customization, ingredient selection, product-concept adaptation, sampling, and private-label development, so the technical infrastructure for an active-led skincare project is clearly present. However, if I were sourcing a PDRN project from TY, I would not assume PDRN expertise purely from its general skincare capacity. I would ask the team to show recent PDRN formulas, identify the exact PDRN or Sodium DNA raw material being used, provide the relevant INCI and COA, explain the proposed addition level, and clarify whether the formula is already stability-tested or would be developed specifically for my project. For a comparison article like this, I think that distinction is important: a manufacturer with strong R&D infrastructure can potentially develop PDRN skincare, but that is different from a factory that publicly demonstrates a mature portfolio of PDRN serums, creams, masks, and other established formats.

Manufacturing Strength

TY Cosmetic’s stronger evidence appears on the manufacturing side. Its official materials state that core production steps are managed in a 100,000-class clean environment under ISO 22716 and GMP systems, with incoming raw-material and packaging inspection, controlled mixing and emulsification, semi-finished-product inspection, filling, packaging, and quality-control procedures forming part of the production workflow. The company publicly lists GMP and ISO 22716 certificates for several manufacturing entities, including Guangzhou Tengyu Cosmetics, Guangzhou Tata Biotechnology, and Guangzhou Meixi Biotechnology, while also showing an Indonesian manufacturing operation and Halal certification for one of its Guangzhou facilities. What I find commercially useful is that TY also lists the supporting documentation it can provide to customers, including ingredient sheets, MSDS, Certificates of Free Sale, product test reports, commodity inspection documents, and marine transportation reports. For international buyers, these details matter more than factory-size figures alone because once a product moves beyond sampling, the supplier must be able to support quality consistency, export preparation, packaging coordination, and documentation at the same time. Its broad category coverage and stated 150-ton daily emulsification capacity also suggest that TY is better positioned for brands expecting to scale or develop multiple product categories than for buyers who only need a very narrow laboratory-style development service.

Best For

From my perspective, TY Cosmetic is best suited to established or growing beauty brands that value manufacturing scale, broad category coverage, OEM/ODM coordination, and the ability to develop several products with one supplier. An e-commerce brand that begins with a PDRN serum but also expects to add moisturizers, masks, sunscreen, hair care, or color cosmetics could find that broader infrastructure useful, and larger distributors may also value the ability to consolidate different product categories through one manufacturing group. I would be less likely to select TY solely because I wanted the most visibly specialized PDRN supplier, since its current public website provides much stronger evidence for general formulation and large-scale beauty manufacturing than for PDRN-specific development. For a serious PDRN project, I would therefore place TY on the shortlist when manufacturing capacity and multi-category expansion are priorities, but I would ask for project-specific PDRN raw-material documentation, formula examples, stability information, MOQ, and recent production experience before making the final comparison with manufacturers whose PDRN capabilities are more openly documented.

Baiyur Beauty

Baiyur Beauty is a Guangzhou-based private label and OEM/ODM skincare supplier operating under Guangzhou Baiyur Co., Ltd., with a business model focused strongly on emerging beauty brands, wholesalers, distributors, salons, and online sellers. What stands out to me is that Baiyur presents itself less as a very large industrial cosmetics group and more as a project-oriented supplier built around flexible order quantities, ready-to-launch formulas, packaging customization, and export coordination. Its current website states more than ten years of export experience, standard private-label MOQs generally between 1,000 and 5,000 units per item, sample preparation of around 7–10 working days, and bulk production of approximately 35–45 working days after formula and packaging approval. One point I would verify carefully before placing a large order is its actual manufacturing structure: Baiyur’s own website says that it works with qualified cosmetic manufacturing partners to provide production, certification documents, and compliance support, rather than clearly presenting all production facilities as wholly owned by Guangzhou Baiyur Co., Ltd. From our perspective at Metro Private Label, that does not automatically make it a weaker sourcing option, but it does mean that serious buyers should confirm which legal manufacturing entity will appear on certificates, batch documentation, and product records before approving a commercial project.

PDRN Skincare Capability

PDRN is one area where Baiyur provides much clearer public evidence than many general OEM manufacturers I reviewed. Its current catalog includes a dedicated PDRN skincare series rather than only one trend-driven serum, with products such as a PDRN Renewal Serum, PDRN Collagen Capsule Cream, PDRN Milky Toner Lotion, PDRN Collagen Peptide Toner Pads, and PDRN Gentle Amino Acid Cleanser. The Renewal Serum uses Sodium DNA alongside niacinamide, ectoin, panthenol, sodium hyaluronate, and adenosine, while its Milky Toner combines Sodium DNA with a ceramide barrier complex, ectoin, and different forms of hyaluronic acid. The cleanser also openly publishes a full INCI list and describes Sodium DNA as a PDRN-related cosmetic ingredient, which is more useful to me than a product page that only uses the word “PDRN” in the title. Baiyur also distinguishes between standard and customized projects: existing formulas with standard packaging generally start from around 1,000 units, while customized formulas or packaging are typically positioned from approximately 3,000 units. This makes its PDRN offering relatively easy to understand commercially. At the same time, I would still ask for the specific Sodium DNA raw-material specification, COA, supplier information, actual addition level, and formula-specific testing before comparing its “PDRN” positioning directly with another manufacturer, because the product name alone does not establish the active basis or concentration.

Manufacturing Strength

Baiyur’s strongest manufacturing proposition appears to be flexibility and coordinated execution rather than sheer industrial scale. Its website describes an OEM/ODM workflow covering product concept, formula and packaging confirmation, sampling and revision, production quality checks, and final export preparation, while its face-care business supports custom texture, fragrance, bottles, jars, labels, retail cartons, logos, and multilingual packaging artwork. For documentation, Baiyur states that selected projects can be supported with ISO 22716:2007 cosmetic GMP documentation, SGS-audited GMP manufacturing documents, COA, MSDS, full INCI information, and U.S. FDA registration or product-listing assistance. From a sourcing standpoint, I find the combination of 1,000-unit ready-formula projects, roughly 3,000-unit custom projects, 7–10 working day sampling, and a 35–45 working day production window more relevant to small and medium brands than impressive but abstract factory-capacity numbers. The trade-off is that buyers should understand exactly which manufacturing partner is assigned to their formula and obtain the corresponding factory certificates and quality documents rather than assuming that every certification shown at the project level applies identically to every product. For a PDRN project, I would also verify whether stability, microbiological, packaging-compatibility, and any market-specific testing are included in the quoted development scope or need to be arranged separately.

Best For

I see Baiyur Beauty as a particularly practical option for small and medium e-commerce brands, distributors, wholesalers, salons, and first-stage skincare businesses that already know they want a PDRN range but do not want to spend months developing every SKU from the beginning. Its existing PDRN cleanser, toner, toner pads, serum, and cream make it possible to build a coordinated product line around one ingredient story, while the approximately 1,000-unit starting MOQ for standard formulas lowers the inventory risk for a brand testing market demand. This model can be attractive to Amazon, Shopify, TikTok Shop, and distributor-led businesses where launch speed, visual consistency across several SKUs, and manageable initial purchasing quantities often matter more than developing highly proprietary biotechnology from scratch. From our perspective as another Guangzhou manufacturer, I would rank Baiyur more strongly for ready-to-launch and semi-custom PDRN projects than for buyers whose first priority is deep proprietary R&D, unusual active specifications, or large multinational procurement programs. Its value is therefore not necessarily having the biggest factory or the most technically complex PDRN platform, but giving commercially minded buyers a relatively straightforward route from an existing product concept to branded inventory with a manageable starting quantity.

Viansh Wellness

Viansh Wellness is a Shanghai-based OEM/ODM manufacturer that positions itself around professional skincare, anti-aging, barrier repair, post-procedure care, and feminine intimate wellness rather than broad mass-market cosmetics. What immediately distinguishes the company from many general private-label suppliers is its clinical positioning: Viansh states that the business was founded by registered clinical nurse Vivian Jiao and uses that background as part of its product-development philosophy, particularly for sensitive-skin, barrier-repair, aesthetic-clinic, and recovery-oriented concepts. From our perspective at Metro Private Label, I see Viansh as a more specialized manufacturer than companies that compete primarily on the number of skincare categories they can produce. Its current website focuses heavily on advanced ingredients such as PDRN, recombinant collagen, Pro-Xylane, peptides, and microbiome-related systems, while also presenting turnkey OEM/ODM support covering formulation, packaging, export preparation, and international documentation. The company states that its products are manufactured through a dedicated Shanghai production base, Shanghai Endless Cosmetics Co., Ltd., rather than leaving the manufacturing entity unclear, which is useful information for buyers carrying out supplier qualification and certification checks.

PDRN Skincare Capability

PDRN is clearly one of Viansh Wellness’s visible development directions rather than a keyword mentioned only occasionally. Its current facial-skincare catalog includes a dedicated “PDRN & Regenerative Tech” category, with publicly listed products such as PDRN Radiant Eye Hydration Serum and PDRN Triple Collagen Post-Procedure Soothing Mask, while its main website also presents a PDRN and Collagen Peptide single-dose ampoule concept. The company further promotes PDRN bio-serums and creams for barrier-repair and post-procedure positioning, which suggests that its PDRN strategy is built more around professional and aesthetic-care routines than around a conventional mass-market hero serum alone. I find this positioning commercially interesting because it gives buyers a clearer route to building a PDRN line around eye care, masks, ampoules, serums, creams, and recovery products rather than simply choosing one stock serum and changing the label. At the same time, I would still verify the exact PDRN raw material, INCI designation, source, COA, concentration basis, recommended addition level, and formula-specific stability data before comparing Viansh’s products directly with another supplier. Its website uses terms such as “marine DNA PDRN,” “clinical,” and “post-procedure,” but experienced buyers should separate marketing positioning from the raw-material and finished-formula documentation that will ultimately support their own market claims.

Manufacturing Strength

Viansh’s strongest manufacturing argument is its combination of specialized formulation positioning and a clearly described controlled-production environment. The company states that its Shanghai manufacturing base covers approximately 10,000 square meters, operates eight automated production lines, uses 100,000-grade cleanroom facilities, and works under ISO 22716 and GMPC quality-management systems. Its certification page also states that the production base is U.S. FDA registered and prepared for MoCRA-related requirements, while technical dossiers such as COA, MSDS, stability documentation, audit materials, and related export-support files are available for customer projects. Viansh additionally highlights testing capabilities involving instruments such as HPLC, GC-MS, and ICP-OES and states that it can support raw-material and finished-product analysis, although I would still ask for project-specific testing scopes rather than assuming every listed test is automatically included in a standard OEM quotation. Commercially, its current medical-aesthetic OEM page indicates a starting MOQ of around 3,000 units and sample support in roughly three to five days, placing the company above some low-MOQ ready-label suppliers but still within a realistic range for established clinics, professional skincare brands, and growing beauty businesses. From our perspective as another manufacturer, this is a useful example of why factory strength should not be judged only by total tonnage: Viansh’s value lies more in controlled production, specialized dosage formats, documentation, and professional skincare positioning than in competing purely on very large-scale commodity output.

Best For

I would consider Viansh Wellness particularly well suited to aesthetic clinics, professional skincare brands, medspa-oriented businesses, and experienced beauty founders that want to build a PDRN range around barrier repair, post-treatment care, premium anti-aging, or professional-use positioning. A clinic that already has microneedling, laser, peel, or skin-rejuvenation programs may find its PDRN masks, eye products, ampoules, serums, and barrier-repair concepts more relevant than the broader catalog of a conventional private-label supplier, while an established beauty brand could also use its PDRN, recombinant collagen, peptide, and Pro-Xylane capabilities to build a more technical product story. I would be less likely to recommend Viansh to a buyer whose only goal is to obtain the lowest possible MOQ or the cheapest ready-to-label PDRN serum, because its approximately 3,000-unit positioning and clinical-aesthetic development model appear better suited to buyers that already have a clear channel, professional positioning, and willingness to invest in a more structured product line. In that sense, I would place Viansh more strongly in the clinic and professional skincare segment of this comparison, while still recommending that international buyers independently verify the exact PDRN specification, market-specific claims, required testing, and compliance responsibilities before approving bulk production.

XJ Beauty

XJ Beauty is a full-turnkey beauty product developer and manufacturer founded in 2007, with a broader international structure than many China-based OEM suppliers in this comparison. Its current operation combines R&D and commercial teams in Orange County, California, Shanghai, Wenzhou, and South Korea, while manufacturing can be coordinated across China, the United States, South Korea, Thailand, and other production locations. The company covers skincare, color cosmetics, bath and body products, hair care, beauty tools, packaging, and accessories, but what I find more relevant from our perspective at Metro Private Label is the way XJ Beauty positions itself around product concept development rather than manufacturing alone. Its turnkey model begins with market direction and product storytelling, then moves through formula development and testing, component sourcing, packaging design, and commercial manufacturing. For brands that already understand their customer but still need help translating a trend into a differentiated product, this model can be valuable because the discussion does not have to begin with a finished formula specification. XJ Beauty also states that products developed through its platform have reached sales volumes above ten million units in recent years, which suggests experience working with commercially scaled beauty programs rather than only small private-label launches.

PDRN Skincare Capability

PDRN is currently a highly visible development topic within XJ Beauty’s skincare content, and I see stronger evidence here than I would from a manufacturer that simply lists one PDRN serum in a catalog. The company has published dedicated development material around PDRN serum, PDRN cream, PDRN balm, PDRN sunscreen, and broader PDRN formulation and manufacturer-selection issues. Its technical content discusses raw-material form, solubility, pH compatibility, preservation architecture, molecular characteristics, carrier selection, packaging compatibility, stability testing, and combinations with actives such as peptides, Centella derivatives, hyaluronic acid, and ceramides. Its private-label PDRN serum guidance also discusses different commercial texture directions, including watery serums, ampoule-style systems, gel serums, milky serums, and formulas combining PDRN with complementary actives. From a manufacturing perspective, this is meaningful because it shows that XJ Beauty is thinking about PDRN as a formulation platform rather than one fixed SKU. I would still verify the exact PDRN or Sodium DNA raw material, INCI name, supplier specification, COA, active basis, addition level, and finished-product testing for any real RFQ, but the public information demonstrates a clear understanding that PDRN development involves stability, delivery, preservation, packaging, and claims control rather than simply adding a trending ingredient to an existing serum base.

Manufacturing Strength

XJ Beauty’s strongest manufacturing advantage appears to be the connection between international product development and a flexible global production network. Its official site describes a full-turnkey process covering product and concept development, formula creation and testing, component sourcing, outer-packaging design, and full-service manufacturing, while its quality-related materials state that production operates under GMP systems with raw-material controls, batch testing, microbiological evaluation, production records, and traceability. What stands out to me is that the company also treats packaging and marketing positioning as part of product engineering rather than as separate activities added after the formula is finished. This is particularly relevant for PDRN products because viscosity, dispensing system, component availability, decoration, formula stability, and claims language can all influence whether a concept reaches production smoothly. Its global R&D footprint may also give international brands an advantage when developing products intended to reflect Korean, Chinese, or U.S. beauty trends while still accessing Asian packaging and manufacturing supply chains. At the same time, I would verify which specific manufacturing facility would produce a PDRN project and request the certificates, testing scope, quality records, and documentation associated with that facility, because a multi-country production network should not be evaluated as though every site automatically operates under identical certifications or capabilities.

Best For

I would place XJ Beauty most strongly among manufacturers suitable for established e-commerce brands, beauty-industry founders, and product teams that want more than a standard ready-to-label PDRN formula. Its combination of trend research, concept development, formulation, packaging sourcing, and multi-country manufacturing makes particular sense for brands that are trying to create a distinctive PDRN product around texture, format, packaging, or consumer positioning rather than compete only on concentration and price. A Shopify or social-commerce brand looking for a PDRN balm, milky serum, cream, sunscreen, or another trend-sensitive format could benefit from that product-development orientation, while an established beauty company planning several categories may value the ability to work across skincare, makeup, hair care, and packaging within the same development network. From our perspective at Metro Private Label, I would position XJ Beauty as stronger in trend-led turnkey product creation and international development coordination than in straightforward low-MOQ private labeling. Buyers whose main priorities are a very small initial order, a simple stock PDRN serum, and the lowest possible launch cost may find a more conventional private-label manufacturer easier to work with, whereas brands that place greater value on concept differentiation, packaging, market storytelling, and scalable development are more likely to benefit from XJ Beauty’s model.

Yangge Biotech

Yangge Biotech Co., Ltd. is a Xi’an, Shaanxi-based ingredient manufacturer and supplier whose core business is much closer to biotechnology raw materials, plant extracts, nutritional ingredients, peptides, APIs, and personal-care ingredients than to conventional finished-skincare contract manufacturing. Its official website states approximately 15 years of industry experience, two production lines, more than 2,000 square meters of facility space, around 50 employees, and exports to more than 80 countries. The company describes an integrated production facility with its own quality and research laboratories and lists ISO, HACCP, Kosher, Halal, ISO 9001, and ISO 22000-related quality credentials across its ingredient portfolio. From our perspective at Metro Private Label, this distinction is important because a buyer searching Google for a “PDRN manufacturer” can encounter both finished-product OEM factories and upstream ingredient companies in the same results. Yangge belongs much more clearly to the second group. Its value is therefore not primarily in taking a skincare brand from bottle design through filling and retail cartons, but in supplying the active raw material that another cosmetic manufacturer may use to develop the finished serum, cream, mask, or other skincare format.

PDRN Skincare Capability

Yangge provides unusually specific public information about its PDRN raw material, which is the main reason I would still consider it relevant in a PDRN sourcing comparison. Its current product page lists cosmetic-grade Polydeoxyribonucleotide in white powder form with a stated 99% specification, HPLC/UV testing, a one-kilogram minimum order, a 24-month shelf life, and small samples available for evaluation. The company describes the material as salmon-derived PDRN and states that COA, MSDS, specification sheets, and third-party retesting through laboratories such as Eurofins or SGS can be arranged. This is useful information for formulation teams because it brings the discussion closer to the actual ingredient specification rather than simply advertising a finished “1% PDRN serum.” Yangge also publishes technical content specifically discussing how PDRN powder can be incorporated into OEM skincare formulas, including considerations around purity, molecular characteristics, concentration, formulation compatibility, and applications such as serums, creams, masks, and professional aesthetic products. However, as a finished-skincare manufacturer ourselves, I would make an important distinction here: supplying a high-purity PDRN powder and understanding its cosmetic applications is not the same as demonstrating a mature portfolio of stability-tested finished PDRN serums or creams. For a real brand project, I would still need to confirm how the raw material behaves within the complete formula, its solubility and processing requirements, the appropriate addition basis, preservative compatibility, pH range, and whether the final product passes the required stability and microbiological testing.

Manufacturing Strength

Yangge’s strongest manufacturing evidence lies upstream in raw-material production, quality control, testing, and global ingredient distribution. The company states that its PDRN powder is tested by HPLC and UV and that batches can be reverified through independent laboratories before shipment, while the wider business provides COA, MSDS, specification documentation, and various quality certificates across its ingredient portfolio. Its PDRN page also offers OEM packaging, custom specifications, private labeling, and different packaging formats, but the context of those services appears primarily to concern the ingredient itself, such as bulk bags, bottles, jars, sachets, and branded raw-material packaging, rather than complete finished skincare manufacturing. This is an important sourcing distinction that I would not hide from readers. If we were developing a PDRN serum at Metro Private Label, a supplier like Yangge could potentially sit at the beginning of our supply chain by providing the active ingredient and technical documentation, while our formulation team would still be responsible for converting that ingredient into a stable serum system, selecting supporting actives, designing the preservation strategy, testing packaging compatibility, conducting finished-product evaluation, and scaling the formula into commercial production. In other words, Yangge’s strength is closer to ingredient traceability and raw-material availability than to turnkey skincare execution, and buyers should verify which part of the development process they actually need before treating it as directly comparable with a traditional OEM/ODM skincare factory.

Best For

I would consider Yangge Biotech most relevant for cosmetic OEM factories, formulation laboratories, experienced skincare brands with their own development resources, and purchasing teams that specifically want to source PDRN raw material rather than buy a finished private-label serum. A brand that already works with a contract manufacturer but wants greater control over the PDRN source, specification, COA, purity, or raw-material cost could find this type of supplier useful, particularly because Yangge offers small samples and a one-kilogram commercial MOQ that can support formulation trials before larger purchasing commitments. It may also be relevant to product developers who want to compare several PDRN raw-material suppliers before deciding which material to incorporate into a proprietary formula. I would be much more cautious recommending Yangge to a first-time Amazon seller, clinic owner, or small brand founder expecting a complete service covering serum formulation, stability testing, bottles, pumps, labels, cartons, filling, and finished-product compliance, because its public website does not currently provide the same level of evidence for turnkey finished-skincare production that we see from dedicated cosmetic OEM manufacturers. In this Top 12 comparison, I would therefore treat Yangge as a useful upstream PDRN specialist rather than pretend it competes in exactly the same way as a full-service private-label skincare factory.

Shiruoni

Shiruoni Cosmetics Co., Ltd. is a China-based private label skincare and personal-care manufacturer that presents itself as a full-service OEM/ODM partner for beauty brands, salons, distributors, and other commercial buyers. What stands out to me is the breadth of its current catalog: beyond conventional face care, the company covers sunscreen, body care, eye care, hair care, lip care, men’s and women’s care, masks, capsule skincare, microneedle-related products, NAD+ concepts, and several other trend-driven categories. Shiruoni states that it has nearly 20 years of formulation and manufacturing experience, its own factory, skincare laboratory support, full customization from formula through container selection and packaging design, and daily production capacity of up to two million pieces. From our perspective at Metro Private Label, this places Shiruoni closer to a broad turnkey manufacturer than a narrowly specialized biotech laboratory. Its current certification section also identifies Shiruoni as the registered company and Yapeng Factory as the certified production facility, which is useful information for buyers who want to understand which manufacturing entity sits behind the commercial brand rather than assuming the website name and production-license holder are always the same company.

PDRN Skincare Capability

PDRN is clearly a developed category within Shiruoni’s current product structure rather than a single trend product added to a general skincare catalog. The company has a dedicated PDRN series and separates its offering into salmon-derived PDRN and plant-derived PDRN concepts, while showing a relatively wide range of finished formats including serums, toners, moisturizers, capsule creams, collagen masks, microneedling serums, eye products, lip treatments, sunscreen-related products, and complete PDRN skincare sets. Its visible catalog currently includes products such as PDRN collagen microneedling ampoules, Centella PDRN serum sets, NAD+ PDRN toner, PDRN collagen elastic serum, plant PDRN bio-needle serum, rose PDRN collagen serum, and PDRN glow cream concepts. This range tells me that Shiruoni is trying to use PDRN as a platform ingredient across multiple textures and delivery formats rather than limiting it to a basic water-based serum. That is commercially useful for a buyer who wants to build a full PDRN collection, but I would still verify the exact raw material behind each formula, especially where the website uses broad terms such as “salmon PDRN” or “plant-derived PDRN.” For an actual sourcing project, I would ask for the INCI name, raw-material supplier specification, COA, concentration basis, recommended usage level, and formula-specific testing before comparing one PDRN product directly with another manufacturer’s percentage or claim.

Manufacturing Strength

Shiruoni’s manufacturing strength appears to be the combination of broad category capability, flexible customization, large daily output, packaging integration, and relatively extensive compliance documentation. Its website states that formulation, packaging selection, label and logo development, and bulk production can be coordinated within one OEM/ODM process, while its certification section shows a cosmetic production license and identifies Yapeng Factory as the production facility associated with the business. The site also lists FDA-MoCRA, FDA-VCRP, FDA-OTC, SGS-ISO, SGS-FDA-GMP, and other factory-related certificates, alongside product-support documents such as CPSR, CPNP, SDS, COA, stability reports, microbial testing, heavy-metal testing, marine transportation reports, and air-transportation reports. I would not assume that every certificate automatically applies to every SKU or destination market, so I would still ask the supplier to provide project-specific copies and confirm which manufacturing entity and formula they relate to. From a manufacturing standpoint, however, this level of public documentation is meaningful because it shows that Shiruoni is used to working with export-oriented projects where the buyer needs more than a sample and a quotation. Its claimed capacity of up to two million pieces per day also suggests that it is designed to support scale beyond small test orders, although the practical MOQ for a specific PDRN product will still depend on formula, packaging, decoration, and customization level.

Best For

I would consider Shiruoni particularly suitable for e-commerce brands, distributors, and growing skincare companies that want to build a broader PDRN product line rather than source only one serum. Its strength lies in product breadth and format flexibility, so a buyer could potentially develop a coordinated collection around cleanser, toner, serum, cream, eye care, masks, or microneedling-related products while keeping formula, packaging, and branding within one manufacturing relationship. This can be especially attractive to Amazon, Shopify, TikTok Shop, and distributor-led businesses that need several commercially recognizable SKUs and want to move quickly between trends without managing multiple suppliers. From our perspective at Metro Private Label, I would place Shiruoni more strongly in the category of broad, trend-responsive turnkey manufacturing than in highly specialized PDRN raw-material science. A buyer with a very detailed technical brief involving a specific molecular specification, tightly controlled active basis, unusual preservative system, or deep proprietary formulation would still need to confirm how much customization is available beyond the existing catalog. For brands that prioritize variety, packaging coordination, export documentation, and the ability to scale a multi-SKU PDRN range, however, Shiruoni is a commercially relevant supplier to include in a China-focused shortlist.

Xiran Skincare

Xiran Skincare is a Guangzhou-based OEM/ODM cosmetics manufacturer with more than a decade of experience in skincare production and a broad private-label portfolio covering face care, body care, eye care, lip care, hair care, men’s skincare, baby care, pregnancy skincare, and other beauty categories. From our perspective at Metro Private Label, Xiran sits in the category of flexible, export-oriented manufacturers rather than a narrowly specialized laboratory. Its current website describes a one-stop model covering custom formulation, packaging, design, production, certification support, warehousing, and shipping, while the company also states that it operates with more than 300 employees, over 10,000 formulas, more than 12 production lines, and daily production above 180,000 units. For buyers, the useful point is not simply the scale itself but the fact that Xiran appears set up to take a project from concept and sampling through packaging and commercial production within one supplier relationship. The company is based in Baiyun District, Guangzhou, which also places it inside one of China’s most concentrated cosmetics manufacturing and packaging ecosystems.

PDRN Skincare Capability

PDRN is one of the more visibly developed active-led categories on Xiran’s current website. The company has a dedicated PDRN collection showing 16 products, including PDRN collagen serum, PDRN peptide serum, PDRN and hyaluronic acid serum, face cream, jelly cream, toner, toner pads, mist, gel mask, eye patches, skincare sets, and vegan PDRN concepts. It also separates its development direction into marine-derived PDRN and plant-based PDRN alternatives, which tells me that Xiran is trying to address different brand positioning needs rather than relying on one standardized PDRN story. Its recent PDRN cream manufacturing content also goes beyond listing finished products and discusses texture development, ingredient matching, packaging, sample testing, production consistency, and export support, which is a more useful signal of actual OEM/ODM capability. At the same time, I would still treat concentration claims carefully. Some current product pages use aggressive marketing language such as “50% Camellia PDRN” or “clinical-strength PDRN,” so for a real sourcing project I would ask for the exact INCI, supplier specification, COA, addition basis, and finished-formula documentation before comparing those numbers directly with another factory’s formula.

Manufacturing Strength

Xiran’s manufacturing strength appears to come from the combination of formula breadth, flexible OEM/ODM support, production infrastructure, and export-oriented documentation. Its production page states that the factory operates a 100,000-grade clean production workshop and works under GMP and ISO-related systems, while the main site says it can provide documents and certificates such as GMPC, ISO 22716, BSCI, FDA-related documentation, MSDS, CPSR support, Certificate of Free Sale, and Certificate of Origin depending on the project. The company also describes ingredient analysis, batch-level quality control, safety assessment, microbial testing, stability testing, and packaging support as part of its contract-manufacturing process. Commercially, its current pages indicate that general stock-packaging projects can begin around 500 units, while conventional lotion, toner, and cream formats are commonly quoted from around 1,000 units; more customized packaging can require higher quantities depending on the component supplier. This is the kind of distinction I pay attention to because it shows that Xiran is positioned to work with both smaller test launches and more customized programs, although buyers should still verify the exact MOQ, testing scope, certification applicability, and production entity for the specific PDRN formula they select.

Best For

I would consider Xiran particularly suitable for e-commerce brands, distributors, beauty-industry founders, and growing skincare companies that want to launch a PDRN range quickly while still retaining room for customization. Its wide PDRN catalog makes it attractive to buyers who may want to begin with one serum or cream and later expand into toner pads, eye care, masks, mist, or a complete skincare set without moving to a second supplier. From our perspective at Metro Private Label, Xiran’s strongest position is in broad PDRN product variety, flexible OEM/ODM execution, and relatively accessible commercialization rather than highly specialized raw-material science alone. An Amazon, Shopify, or TikTok operator may value the combination of 500–1,000-unit starting points, packaging support, and multiple trend-ready formats, while a distributor could use the same breadth to build a multi-SKU range more efficiently. For an experienced brand with a very strict technical brief, however, I would still verify the raw-material specification, active basis, formula testing, and claims support carefully, especially where the public product pages use strong PDRN percentages or efficacy language. Overall, Xiran is a commercially relevant option for buyers who prioritize speed, breadth, and flexible private-label development within one Guangzhou manufacturing partner.

Desifine

Desifine, operating as Guangdong Desifine Biotechnology Co., Ltd., is a Guangzhou-based cosmetics OEM/ODM manufacturer founded in 2000 and located in Nansha District. Compared with many suppliers that mainly compete through a large ready-formula catalog, Desifine positions itself more heavily around formulation R&D, functional skincare, quality systems, and what it describes as German-style manufacturing management. The company states that its production base covers approximately 15,000 square meters and combines product planning, formula development, commercial production, testing, packaging customization, and export support within one manufacturing platform. Its current website also presents more than 800 brands served, a formulation library exceeding 10,000 formulas, and broad capabilities across face care, masks, eye care, body care, hair care, makeup, lip care, men’s care, and baby care. From our perspective at Metro Private Label, Desifine is therefore better understood as an established functional-skincare OEM/ODM manufacturer than as a factory built only around PDRN. That broader manufacturing base can be useful for a brand that begins with a PDRN serum but expects to develop creams, masks, eye products, or other categories later under the same supplier relationship.

PDRN Skincare Capability

PDRN is one of the advanced active categories that Desifine currently promotes quite strongly, and its public material provides more formulation-specific detail than I see from many general private-label factories. Desifine describes its PDRN program around facial repair serums, post-procedure ampoules, and anti-aging firming serums, with different concentration and positioning options available for customization. More notably, the company claims to use low-temperature emulsification together with an “8-Free” clean-formulation approach to reduce the risk of PDRN degradation during formulation, and it presents active stabilization as one of its main technical differentiators. From a manufacturer’s point of view, I find the focus on processing conditions more meaningful than simply showing another “1% PDRN serum,” because temperature, preservation, pH, raw-material specification, and the surrounding formula system can all influence whether an active-led concept remains commercially stable. At the same time, these are claims I would still verify at project level. Before comparing Desifine’s PDRN formulas directly with another factory, I would ask for the exact PDRN or Sodium DNA raw material, INCI name, supplier COA, concentration basis, recommended addition range, finished-formula stability data, and clarification of what its low-temperature processing actually means for the selected formula. That kind of verification is more useful to an experienced buyer than relying only on terms such as “high concentration,” “clean formula,” or “activity stabilization.”

Manufacturing Strength

Desifine’s manufacturing strength appears to come from the combination of R&D depth, controlled production, export experience, and a relatively mature quality-management system. Its current company materials describe a 15,000-square-meter manufacturing facility, a 100,000-class clean production environment, six automated production lines in its PDRN manufacturing profile, and a research team of more than 20 engineers. The company also publicly shows ISO 22716 certification and states that it operates with GMPC and FDA-related registration or compliance systems, while its broader OEM/ODM model covers formulation, fragrance, texture, concentration, bottles, labels, logos, and other packaging elements. Desifine also emphasizes stability evaluation before market release, including accelerated and temperature-cycle testing, which is particularly relevant for active-led formulas where an attractive laboratory sample is not enough to prove commercial readiness. Its current PDRN materials describe approximately 45 to 60 days from formula confirmation to commercial delivery and position the company as capable of supporting both lower-MOQ testing programs and larger repeat orders. From our perspective at Metro Private Label, the useful strength here is not simply the number of production lines; it is the apparent ability to combine formula development, manufacturing controls, packaging, and international project documentation within one workflow. As with any supplier, however, I would confirm the exact testing included in the quotation, which certificates apply to the actual production entity, and what documents are supplied for the specific PDRN formula rather than assuming that every general factory credential automatically covers every project.

Best For

I would consider Desifine particularly relevant for growing and established skincare brands that want more formulation involvement than a simple ready-to-label PDRN product but still prefer to work within a mature OEM/ODM platform. Its combination of functional-skincare R&D, PDRN-specific formulation positioning, packaging customization, quality systems, and export experience can suit beauty-industry founders who already understand product development, cross-border e-commerce brands that need a differentiated PDRN hero SKU, and established brands planning to expand one PDRN product into a broader anti-aging or repair range. I would also see it as a stronger fit for buyers who value formulation discussion and technical positioning rather than selecting a product purely from a stock catalog. From our perspective at Metro Private Label, Desifine’s clearest differentiation in this comparison is R&D-oriented functional skincare combined with an established manufacturing platform and a publicly articulated PDRN stabilization strategy. A buyer whose only requirement is the absolute lowest cost or the smallest possible order may find a simpler ready-label supplier more efficient, while brands with highly specific PDRN technical requirements should still verify raw-material traceability, active basis, testing, and formula documentation during the RFQ stage before treating the public stabilization claims as confirmed project specifications.

Aisen Pro Skin

Aisen Pro Skin, operated by Guangzhou Aisen Biotechnology Co., Ltd., is a Guangzhou-based skincare OEM/ODM manufacturer with a broad development platform covering facial skincare, body care, scalp and hair care, baby care, and eye care. From our perspective at Metro Private Label, Aisen stands out less because of category breadth alone and more because of the way it presents its R&D and manufacturing system around active-led skincare development. The company states that it has been operating since 2007, has developed more than 3,000 formulas, and operates a manufacturing facility of approximately 20,000 square meters with 12 production lines and annual capacity of up to 80 million units. Its current company materials also highlight a research team led by eight PhDs in areas such as genetic engineering, materials science, and chemistry, together with microencapsulation technology, formulation customization, packaging development, quality control, and export documentation support. As another Guangzhou manufacturer, I see Aisen as a relatively structured OEM/ODM supplier rather than a simple catalog-based private-label company, because its public positioning focuses on taking a product from concept and market direction through formula development, packaging, testing, bulk production, and export preparation within one workflow.

PDRN Skincare Capability

Aisen provides clear public evidence of PDRN product development, which is important in a comparison where many manufacturers only mention the ingredient once or twice. Its current product range includes an Anti-Aging and Brightening Salmon PDRN Facial Serum, a Salmon DNA Pink Peptide 12 PDRN Serum, and a broader Salmon Pink Peptide skincare set combining toner, serum, cream, and gel mask concepts. One of its highlighted formulas uses 10,320 ppm Sodium DNA together with 12 peptides, niacinamide, hydrolyzed collagen, and bakuchiol, while the company states that PDRN concentration, peptide blends, supporting actives, and packaging can be customized for private-label projects. Aisen also publishes formulation content discussing molecular size, oxidation risk, encapsulation, stability, and sensitive-skin positioning, which suggests that it is treating PDRN as part of a formulation system rather than only as a marketing headline. That said, I would still verify the exact Sodium DNA raw-material supplier, COA, concentration basis, molecular specification, addition level, and finished-formula test data before comparing its PDRN percentages directly with another factory. The website uses strong efficacy language and internal performance figures, so an experienced buyer should separate the manufacturer’s commercial positioning from the claims and evidence that can actually be used in the destination market.

Manufacturing Strength

Aisen’s manufacturing strength is one of the more substantial parts of its profile. The company states that its production environment operates under ISO 22716 and GMPC systems with a 100,000-class cleanroom, RO and EDI ultrapure-water systems, ozone sterilization, and a five-stage quality-control process covering raw-material inspection, in-process monitoring, packaging checks, and finished-product verification. It also describes 720-hour stability or destructive testing and retained samples for batch traceability, while its current factory information cites daily output of around 200,000 facial masks and 100,000 bottles or tubes. For PDRN development, this matters because the challenge is not simply producing a convincing sample; the same viscosity, active system, packaging compatibility, microbiological stability, and appearance need to remain consistent when the project moves into repeat commercial batches. Aisen’s published MOQ guidance is also commercially relevant: regular skincare such as serums, creams, and lotions is generally positioned around 1,000 to 2,000 units per SKU, with some trial programs in the 500 to 1,000-unit range, while standard sampling is stated at roughly three to seven working days and bulk production at around 15 to 25 working days after formula and packaging confirmation. The company also states that it can assist with COA, MSDS, product specifications, CPNP-related documentation, Halal, FDA-related files, and global delivery. From our perspective as a manufacturer, the combination of R&D, quality control, low-to-medium MOQ, and scalable production is more valuable than capacity numbers alone because it suggests that Aisen can serve both test launches and larger repeat orders within the same production system.

Best For

I would consider Aisen Pro Skin particularly suitable for growing e-commerce brands, beauty-industry founders, clinics, and established skincare companies that want a PDRN product with more formulation depth than a basic stock serum. Its current PDRN direction around Salmon DNA, peptide combinations, bakuchiol, barrier support, and sensitive-skin positioning makes it especially relevant to brands building anti-aging, skin-longevity, repair, or K-beauty-inspired product concepts. An Amazon or Shopify operator could benefit from the combination of a 1,000-unit commercial starting point, custom concentration options, packaging support, and relatively short development timelines, while an experienced founder may value the ability to adjust active systems and develop a broader PDRN routine instead of sourcing a single hero SKU. From our perspective at Metro Private Label, Aisen’s clearest strength is the combination of active-led R&D, microencapsulation positioning, controlled manufacturing, and scalable OEM/ODM execution. I would still recommend that technically demanding buyers verify the exact PDRN material, formulation test data, packaging compatibility, and market-specific claims before approving bulk production, but for brands that want a balance between customization, research support, manageable MOQ, and production scale, Aisen is a commercially relevant manufacturer to include in a China-focused PDRN shortlist.

Blackbird Skincare

Blackbird Skincare is a China-based private-label skincare sourcing and project-management company focused on international beauty brands, e-commerce sellers, and growing skincare businesses. One distinction I think buyers should understand before comparing it with a factory such as Metro Private Label is the company structure behind the brand. Blackbird’s own About page explains that the business originated from a family manufacturing operation, established a foreign-trade division in 2009, and then formally created Blackbird as a foreign-trade company in 2015 to handle international skincare sourcing and production projects. Its founder also describes returning to the family business, Heruun, before establishing Blackbird to develop the export and private-label side of the operation. Based on that information, I would describe Blackbird itself as a trading and private-label service company backed by manufacturing resources rather than automatically treating Blackbird Skincare as the legal factory entity. This does not mean that it lacks production capability; its role appears to be coordinating formula development, raw-material and packaging sourcing, sampling, production, quality inspection, and international delivery through the manufacturing resources behind the business. From our perspective at Metro Private Label, this distinction matters because buyers carrying out supplier due diligence should always confirm which legal company owns or operates the production facility, which entity appears on ISO or GMPC certificates, and which manufacturer will actually be responsible for their commercial batch.

PDRN Skincare Capability

Blackbird provides clear public evidence that PDRN is part of its current private-label development portfolio. Its dedicated PDRN page presents a relatively broad range covering facial serums, face creams, eye creams, facial masks, ampoules, cleansers, toners, sunscreens, moisturizers, lotions, sleeping masks, facial mists, and targeted spot products, while the company also states that formulas can be adjusted around texture, complementary ingredients, concentration direction, packaging, and brand positioning. This breadth makes Blackbird commercially relevant for buyers who want to create an entire PDRN concept rather than source only one serum. However, I would evaluate this capability from the perspective of a sourcing and project-management company rather than assume that every formula is developed and manufactured within a Blackbird-owned laboratory or factory. For an actual PDRN project, I would ask which production facility will make the formula, what PDRN or Sodium DNA raw material will be used, whether the supplier can provide the INCI and COA, what the stated concentration represents, and what stability and microbiological testing has already been completed. Its public PDRN pages contain strong claims around regeneration, collagen stimulation, post-treatment repair, and other efficacy language, so an international buyer should also separate marketing copy from the evidence and claims that can legally be supported in the target market.

Manufacturing Strength

Blackbird’s practical strength appears to lie in supply-chain integration and access to manufacturing resources rather than in the foreign-trade company itself being the factory. Its About page describes a production base with approximately 2,000 square meters of 100,000-level clean production space, 13 daily production lines, two automatic filling lines, a 500-square-meter laboratory, and a technical team of around 15 engineers, while also stating that production follows ISO 22716 and GMPC-related standards. The same page says Blackbird manages the full supply chain from development and raw-material sourcing through packaging, manufacturing, quality inspection, and delivery. From a buyer’s perspective, that structure can still be useful because one commercial team can coordinate formulation, packaging suppliers, production, QC, and logistics without the brand managing multiple vendors independently. Blackbird also promotes a starting MOQ of around 1,000 units for many private-label projects, which is suitable for smaller e-commerce brands testing new SKUs. The point I would verify carefully is ownership and accountability: before approving production, I would request the actual factory business license, ISO 22716 or GMPC certificates, production-license information, factory name shown on the documents, and confirmation that the certificates correspond to the site producing the PDRN product. This is especially important when working through a trading or sourcing structure because the strength of the project ultimately depends on the manufacturing partner selected behind the commercial company.

Best For

I would consider Blackbird Skincare particularly suitable for Amazon, Shopify, TikTok, and other DTC brands that value one-stop sourcing, relatively low starting quantities, broad product choice, packaging coordination, and a single English-speaking commercial team managing the project from concept to shipment. Its PDRN catalog is wide enough for a buyer to begin with a serum and later extend into creams, masks, eye care, ampoules, or other related products without sourcing every SKU independently. Distributors and first-stage brands may also find this model practical because the foreign-trade structure can simplify communication, supplier coordination, packaging sourcing, and export logistics. From our perspective at Metro Private Label, however, I would place Blackbird more strongly in the category of private-label sourcing and supply-chain coordination backed by manufacturing resources rather than direct factory ownership. Buyers that prioritize convenience, product variety, and project management may find that model attractive, while experienced brands that require direct access to the actual factory, strict supplier audits, raw-material traceability, or highly technical PDRN formulation discussions should verify the underlying production entity and technical team before placing Blackbird on the same level as a directly owned manufacturing facility.

Dr. Rashel BBG

Dr. Rashel is a large international beauty and personal-care brand supported commercially by Yiwu Rashel Trading Co., Ltd., a Chinese trading company responsible for brand operation, global agency and distribution, export business, and customized product services. This company structure is important when I compare it with a directly operated cosmetics factory. Dr. Rashel’s own website describes the brand as primarily a skincare-focused beauty brand and identifies Yiwu Rashel Trading Co., Ltd. as the business entity behind its international operations, while stating separately that its products are manufactured at production facilities in Guangzhou. From our perspective at Metro Private Label, I would therefore describe Dr. Rashel as a brand and foreign-trade/OEM service organization connected to Chinese manufacturing resources rather than automatically describing Yiwu Rashel Trading Co., Ltd. itself as the factory. The company has a significant international footprint, particularly across the Middle East, Africa, Southeast Asia, Central Asia, Russia, South America, and other emerging beauty markets, and its current website states that Dr. Rashel products are exported to more than 130 countries. The brand also covers a much broader portfolio than PDRN alone, including face care, sun care, hair care, body care, baby care, men’s care, makeup, and ingredient-led ranges built around Vitamin C, niacinamide, hyaluronic acid, collagen, ceramides, retinol-related concepts, and other familiar consumer ingredients. For buyers, this means Dr. Rashel should be understood first as a commercially mature beauty brand and distribution platform with OEM/ODM services, rather than as a specialist PDRN formulation laboratory.

PDRN Skincare Capability

PDRN is clearly part of Dr. Rashel’s current ingredient strategy, but I would rate the public evidence for its PDRN specialization more cautiously than manufacturers that show extensive dedicated PDRN serum, cream, mask, and technical-formulation pages. The official website includes PDRN as one of its highlighted skincare ingredient categories alongside Vitamin C, retinol, niacinamide, hyaluronic acid, salicylic acid, ceramides, collagen, snail, and rice, and its service information also names PDRN among the hero actives used across the brand’s science-led skincare development. However, the current dedicated PDRN category provides relatively limited technical detail about specific finished formulations, raw-material specifications, concentrations, molecular characteristics, or individual PDRN SKUs. From our perspective as a manufacturer, that distinction matters. A company can clearly have access to PDRN formulation resources without publicly demonstrating the same depth of PDRN specialization as a supplier whose website shows multiple formulas, raw-material discussions, stability considerations, and concentration options. If I were evaluating Dr. Rashel for a private-label PDRN project, I would therefore ask the commercial team to provide the exact existing PDRN formulas available for OEM, identify whether Sodium DNA or another PDRN-related raw material is being used, provide the INCI, raw-material COA and specification, explain the addition basis, and show the stability and microbiological documentation for the proposed finished product. This is especially important because a buyer should not assume that a general brand statement such as “we use PDRN” tells them enough to compare the technical quality of one factory’s serum with another.

Manufacturing Strength

Dr. Rashel presents substantial manufacturing resources behind its commercial and trading structure, although I would keep a clear distinction between those production resources and the Yiwu trading company itself. The official service information states that products are manufactured in Guangzhou and describes an intelligent production system with around 70 automated production lines covering raw-material sourcing and inspection, formula development and sampling, filling and packaging, finished-product inspection, retention samples, and batch traceability. The company also states that it can support documentation such as COA, MSDS, ingredient lists, testing reports, filing documents, and selected ISO, BSCI, SEDEX, or other audit materials depending on the customer’s market requirements. These are meaningful capabilities for distributors and private-label buyers that need scale, repeatability, and export coordination. At the same time, if I were conducting supplier qualification for a serious PDRN project, I would ask for the name and business license of the actual Guangzhou manufacturing entity, its cosmetic production license, ISO 22716 or GMPC certificates, and confirmation that those certificates apply to the site producing my specific order. This is a normal part of due diligence when the contracting or export-facing company is a trading entity rather than the factory shown on the manufacturing documents. From our perspective at Metro Private Label, Dr. Rashel’s strength is therefore best understood as a combination of established brand scale, international distribution experience, high-volume manufacturing access, and export-oriented project coordination rather than direct evidence that the Yiwu trading company itself operates the production lines.

Best For

I would consider Dr. Rashel particularly relevant for distributors, wholesalers, regional beauty retailers, and commercial buyers that already have established sales channels and want access to a broad, internationally recognized beauty-product ecosystem rather than a highly specialized PDRN development partner. Its existing strength in the Middle East, Africa, Central Asia, Southeast Asia, and other price-sensitive but fast-growing beauty markets can be valuable for buyers who understand those channels and prioritize product variety, recognizable ingredient concepts, competitive positioning, scalable supply, packaging support, and international logistics. Its OEM/ODM service may also suit businesses that want to adapt proven skincare concepts under their own brand while working through one export-facing commercial team. From our perspective at Metro Private Label, I would place Dr. Rashel more strongly in the category of large-scale brand, trading, distribution, and OEM coordination than in specialist PDRN formulation development. An experienced beauty founder looking for an unusual PDRN raw-material specification, tightly controlled concentration basis, sensitive-skin preservation system, or deep technical collaboration should first verify how much direct access they will have to the underlying Guangzhou formulation and manufacturing team. For distributors and channel-driven buyers that value range breadth, supply scale, international market experience, and commercial execution, however, Dr. Rashel remains a relevant company to include in a China-focused PDRN sourcing comparison.

Which Chinese PDRN Manufacturer Is Best for Your Business

When I compare PDRN manufacturers, I do not think the most useful question is “Which company ranks first?” The better question is “Which supplier fits the way my business actually operates?” A manufacturer that is excellent for a distributor buying several ready-made SKUs may be the wrong choice for a founder who wants a highly customized serum, while a factory built for large-volume programs may create unnecessary cost and complexity for an e-commerce brand testing 1,000 units. This is why I prefer to look at MOQ, development speed, formulation depth, packaging, documentation, production continuity, and future scaling together rather than judging factories on size alone. In practice, the best supplier is usually the one whose production model matches the buyer’s sales channel, decision speed, budget, technical expectations, and repeat-order plan.

Best for E-commerce Brands

For Amazon, Shopify, TikTok Shop, and other DTC brands, I would prioritize manufacturers that can move quickly without sacrificing basic formulation and compliance discipline. These businesses often work against launch windows, advertising calendars, seasonal demand, and inventory pressure, so a 500- to 1,000-unit starting point, fast sampling, clear packaging options, and predictable replenishment can matter more than access to the largest possible factory. Metro Private Label, Xiran Skincare, Baiyur Beauty, Shiruoni, and Aisen Pro Skin are all commercially relevant in this segment because they combine relatively accessible project sizes with multiple PDRN product formats and packaging support, while XJ Beauty becomes more interesting when the brand wants stronger trend research, visual differentiation, or more complex product concepts. What I would look at most carefully is whether the supplier can provide not only a good first sample but also stable repeat production, suitable bottles and pumps for e-commerce fulfillment, clear INCI and documentation, and the ability to replenish before a product goes out of stock. For these buyers, the right manufacturing partner is not simply the one with the lowest quotation; it is the one that can keep the product commercially available while helping the brand move fast enough to take advantage of a market opportunity.

Best for Beauty Industry Founders

Experienced beauty founders usually need a different type of relationship because they often arrive with stronger opinions about skin feel, active combinations, target concentration, packaging, claims, and long-term brand architecture. In this case, I would give more weight to manufacturers such as Metro Private Label, Desifine, Aisen Pro Skin, XJ Beauty, and Viansh Wellness, where the public positioning places more emphasis on formulation development, active-led concepts, technical communication, or specialized skincare systems. The important difference is that these buyers are not simply asking for “a PDRN serum”; they may want a particular viscosity, a cleaner preservative direction, a peptide or ceramide combination, a specific type of PDRN raw material, or a product that can later expand into a cream, eye treatment, mask, or complete range. I would therefore judge the supplier by how well its R&D team can explain trade-offs, how many sample revisions it can realistically support, whether the team understands why one active combination is more practical than another, and whether the factory can preserve consistency as the brand adds future SKUs. For an experienced founder, the best manufacturer is usually the one that can speak both formulation language and brand language rather than simply quoting MOQ and lead time.

Best for Distributors and Retail Buyers

For distributors, wholesalers, and retail buyers, I would shift the decision toward ready formulas, range breadth, cost stability, repeat production, and the ability to source several SKUs through one supplier. Baiyur Beauty, Shiruoni, Xiran Skincare, Dr. Rashel BBG, and Blackbird Skincare are more relevant in this context because their commercial models place greater emphasis on product variety, packaging coordination, multi-SKU programs, or export-facing supply-chain management. A distributor usually does not need six months of formulation work if the goal is to test whether PDRN toner, serum, cream, and masks can sell through an existing channel. What matters more is whether the formulas are mature, whether different SKUs can share a consistent packaging identity, whether the supplier can provide clear pricing across several order quantities, and whether production can continue without frequent component changes or unexpected delays. I also pay attention to labeling and carton execution because distributors often need barcodes, multilingual information, outer-carton marks, and retailer-ready packaging handled efficiently. For this buyer type, the best supplier is generally the one that reduces operational friction and allows the buyer to test products quickly, identify winners, and then scale those winners without rebuilding the supply chain.

Best for Clinics and Professional Skincare Businesses

Clinics, medspas, aesthetic centers, and professional skincare businesses usually need a supplier that understands product systems rather than isolated trend products. I would look more closely at Metro Private Label, Viansh Wellness, Aisen Pro Skin, and selected manufacturers with visible barrier-repair, sensitive-skin, post-treatment, mask, ampoule, or professional skincare capabilities. These buyers often already have an existing client base, so the commercial opportunity is not only to sell a product once but to create a repeat-purchase routine around treatments, memberships, and home care. That means the formula needs to feel gentle and professional, the packaging has to support trust, and the product line should make sense as a system, for example a recovery serum followed by a barrier cream and mask rather than several unrelated PDRN SKUs. I would also be more conservative with claims in this channel because clinics are highly sensitive to irritation, client complaints, and overpromising. From my perspective, the best manufacturer for a clinic is one that can balance repair positioning, formulation stability, professional packaging, documentation, and repeat-use logic while helping the clinic build a credible retail range around its existing treatment business.

PDRN Is Not One Standard Raw Material

One of the most important things I try to clarify with buyers is that “PDRN” is not a single standardized cosmetic raw material that every factory purchases in exactly the same form and at the same concentration. In real sourcing conversations, buyers may encounter PDRN, Sodium DNA, salmon-derived DNA ingredients, plant-derived or vegan PDRN-positioned materials, and supplier-specific complexes all being presented under similar marketing language, even though their specifications and formulation behavior can be quite different. This is why I think PDRN sourcing becomes confusing very quickly once quotations from several factories are placed side by side. Two suppliers may both advertise a “1% PDRN serum,” but unless the buyer understands the ingredient identity, raw-material specification, concentration basis, and actual addition level, those two percentages may not be technically comparable at all. From a procurement perspective, the useful question is therefore not simply “How much PDRN is in the formula?” but “What exactly is the PDRN-related material being used, and what does this percentage represent in the finished product?”

PDRN and Sodium DNA Are Often Used Differently in Commercial Discussions

In cosmetic sourcing, I often see PDRN used as the commercial or marketing term while Sodium DNA appears as the ingredient name on technical documents or the finished INCI list. Buyers sometimes assume those two terms are automatically interchangeable in every situation, but I would not make that assumption without looking at the underlying raw material. A supplier may describe a formula as “PDRN skincare” because the ingredient positioning is easier for consumers to recognize, while the actual raw-material documentation identifies Sodium DNA with a particular source, purity, molecular profile, carrier system, or concentration. This does not mean the product is misleading, but it does mean that the commercial name and the technical specification serve different purposes. When I compare suppliers, I therefore want to see how the material is identified on the INCI, what the raw-material supplier calls it, how the manufacturer describes its concentration, and whether those descriptions remain consistent from quotation to COA and finished-formula documentation. That consistency matters much more to me than whether the product page uses the most fashionable PDRN terminology.

Salmon-Derived DNA Ingredients Need More Than a “Salmon PDRN” Label

Salmon-derived PDRN is one of the most familiar positioning directions in the market, particularly because buyers often associate it with Korean aesthetic skincare and regenerative beauty concepts. However, the phrase “salmon PDRN” on a product page does not tell me enough about the actual ingredient being used. I still want to know the supplier, source, specification, purity or concentration basis, molecular characteristics where relevant, recommended usage range, and what technical documents can be provided. This is especially important when different manufacturers quote very different prices for products that appear similar on the surface. One supplier may be using a more concentrated raw material, another may be using a diluted solution, and another may be buying a supplier-specific complex that contains Sodium DNA together with solvents, humectants, or other supporting components. Without those details, a buyer can easily mistake a higher headline percentage for a stronger or more premium formula when the real difference lies in the raw-material specification rather than the number printed on the quotation.

Plant-Derived and Vegan PDRN-Positioned Ingredients Should Be Evaluated Separately

I also see more plant-derived, vegan, and alternative PDRN-positioned ingredients entering the private-label market as brands look for ways to avoid animal-origin stories while still participating in the PDRN trend. These materials can be commercially useful, especially for vegan-positioned brands or markets where ingredient origin plays a strong role in consumer decision-making, but I would not compare them directly with salmon-derived materials as though they were technically identical. The supplier may be using a different nucleic-acid source, fermentation-derived material, botanical DNA-related ingredient, or a proprietary complex designed to deliver a similar marketing direction without the same origin. From a sourcing standpoint, this is not necessarily a problem; the problem begins when several fundamentally different materials are all reduced to the same “PDRN” percentage in a quotation. I would therefore treat plant-derived or vegan PDRN-positioned ingredients as a separate formulation and positioning choice, and I would ask the manufacturer to explain exactly what the material is, how it should appear in the INCI, what documentation supports its origin, and what claims are realistic for the destination market.

Supplier-Specific PDRN Complexes Can Make Percentage Comparisons Even More Misleading

Another area that creates confusion is supplier-specific PDRN complexes. Some raw-material suppliers do not sell a single isolated ingredient in the way buyers may imagine; instead, they offer a solution or complex containing PDRN-related material together with water, solvents, humectants, stabilizers, or other functional components. A cosmetic factory may then add 1%, 2%, or even more of that supplied complex into the finished formula, and the quotation may describe that addition level as the “PDRN percentage.” From a formulation perspective, this can be perfectly normal, but commercially it becomes dangerous when the buyer compares that number directly with another manufacturer using a different raw material. A factory adding 1% of a highly diluted complex and another using 0.2% of a much more concentrated material may create completely different finished active levels even though the first quotation appears stronger. This is why I always separate three numbers in my mind: the concentration of the supplied raw material, the amount of that raw material added to the formula, and the resulting level of the relevant active component in the finished product. If those three are not clear, the percentage alone does not help me make a reliable purchasing decision.

Never Compare Two PDRN Products by Percentage Alone

This is the procurement lesson I consider most important in the entire category. Buyers should never assume that a 1% PDRN serum is automatically stronger, more effective, or more valuable than a 0.5% serum simply because the number is higher. Before making that comparison, I want to know whether both manufacturers are using the same type of raw material, whether the concentration basis is identical, whether the addition percentage refers to the supplied solution or the active content, and whether the finished formulas have been developed and tested under comparable conditions. Price should also be interpreted in this context. A more expensive quotation may reflect a higher-cost raw material, stronger documentation, a different specification, more complex preservation, or additional stability work, while a cheaper formula may simply be based on a very different ingredient basis. From my experience, this is where experienced buyers separate themselves from trend-driven sourcing: they stop asking only “What percentage do you use?” and start asking “What exactly does that percentage mean?”

What I Would Ask for Before Approving a PDRN Formula

Before I treat a PDRN quotation as technically meaningful, I want the supplier to provide enough information for the ingredient and finished formula to be understood as one system rather than a marketing claim. At minimum, I would expect the INCI name, raw-material supplier information, COA, raw-material specification, recommended usage guidance, the actual addition level used in the formula, and finished-product documentation that shows how the ingredient is represented in the commercial product. Depending on the project, I would also want clarity on source, molecular characteristics, preservation, pH, stability, packaging compatibility, and any market-specific claim limitations. The goal is not to turn every buyer into a cosmetic chemist; it is to make sure the sourcing decision is based on comparable information. Once those details are available, the buyer can meaningfully compare cost, concentration, formulation strategy, documentation quality, and supplier capability. Without them, two PDRN quotations may look precise while actually describing completely different products.

How to Evaluate a PDRN Manufacturer Before Sending an Order

Before I send a deposit or approve bulk production, I want to understand much more than whether the factory can make a PDRN serum and how much it costs per bottle. In real sourcing projects, the most expensive mistakes usually happen when the buyer compares quotations too quickly and assumes that the same product name means the same raw material, formula structure, documentation, packaging, or production scope. A reliable supplier evaluation should therefore cover the ingredient itself, the finished formula, preservation, packaging, certificates, export documents, MOQ structure, and realistic lead time as one connected system. I see this stage as less about finding the cheapest manufacturer and more about identifying whether the supplier can consistently reproduce the product I am actually trying to launch.

Confirm the Raw Material

The first thing I confirm is the exact PDRN-related raw material the manufacturer plans to use. I want to know the INCI name, supplier, origin, commercial specification, COA, and whether the ingredient is salmon-derived, Sodium DNA-based, plant-derived, fermentation-based, or part of a proprietary complex. I also want to know whether the factory is purchasing the material directly from an established raw-material supplier or through another intermediary, because traceability becomes important if there is ever a documentation question or batch issue later. In my experience, suppliers that can explain the raw material clearly usually make the rest of the project easier because formulation, claims, pricing, and compliance all become more transparent. If the answer is only “we use high-quality PDRN” without a usable specification, I would not treat that as enough information for a serious project.

Confirm What the PDRN Percentage Means

Once the raw material is identified, I clarify what the quoted PDRN percentage actually represents. This is one of the most common points of confusion in the category because 1% can mean very different things depending on whether the factory is referring to the amount of a premixed raw-material solution, the concentration of Sodium DNA in that solution, or the final level of a defined active in the finished product. Before comparing two quotations, I want both manufacturers to explain the same concentration logic. Otherwise, a 1% formula from one supplier may not be stronger than a 0.5% formula from another at all. I also prefer to see that explanation reflected consistently across the formula sheet, COA, technical specification, and commercial quotation rather than only in sales messaging. When the percentage basis is clear, I can then make a more meaningful decision about cost, positioning, and whether the active level is technically reasonable for the product.

Check Formula Stability

A promising sample is not enough for me to approve production because a serum that looks good after three days may behave very differently after months of storage, temperature changes, transportation, or repeated opening and closing. I therefore ask what stability work has already been completed on the proposed formula and whether the manufacturer has evaluated appearance, color, odor, viscosity, pH, separation, precipitation, and other relevant changes over time. For customized PDRN products, I also want to know whether the formula is based on an already validated system or whether the specific active combination is still in development. This matters particularly when PDRN is combined with peptides, niacinamide, ceramides, acids, botanical extracts, or other ingredients that may change the stability profile. I do not expect every supplier to have identical testing protocols, but I do expect them to explain what has been tested, what is still pending, and what additional validation may be required before a commercial launch.

Review Preservation Strategy

Preservation deserves separate attention because many PDRN buyers request sensitive-skin, clean-beauty, phenoxyethanol-free, or minimalist positioning without realizing that every exclusion changes the formulation challenge. When a manufacturer agrees to remove a preservative, I want to know what will replace it, how the complete preservation system works, what pH range it requires, and whether the system has been challenge-tested or otherwise validated for the proposed formula. I am much more comfortable with a supplier that explains why a requested preservative restriction creates trade-offs than one that simply says “yes” and removes an ingredient without discussing microbiological protection. The commercial risk here is significant because a preservation failure can lead to complaints, recalls, damaged reviews, or even regulatory consequences. For me, a premium PDRN ingredient has little value if the surrounding formula is not microbiologically robust enough to remain safe during its intended shelf life.

Evaluate Packaging Compatibility

Packaging is another area I evaluate before I treat the formula as production-ready. I want to know whether the serum or cream has been tested with the selected bottle, pump, dropper, tube, jar, or airless system, because viscosity and component design can directly affect dispensing, leakage, air exposure, and customer experience. A packaging sample may look premium but still create problems if the pump output is inconsistent, the formula dries around the nozzle, the bottle leaks in transit, or the material is not compatible with the finished formula over time. For e-commerce brands, I also think about shipping conditions, secondary packaging, protective inserts, and whether the finished unit can survive fulfillment without creating unnecessary returns. In practice, I see formula and packaging as one product system rather than two separate purchasing decisions, so I prefer manufacturers that are willing to test compatibility before bulk production instead of assuming that any bottle can be used with any PDRN formula.

Verify Certifications

I also verify the manufacturer’s quality and production certificates rather than relying only on logos shown on a website. ISO 22716 and GMPC are useful signals, but I want to confirm the legal company name, factory address, validity period, and whether the certificate corresponds to the actual site that will produce my order. This becomes especially important when the commercial contact is a trading company, sourcing company, or brand operator rather than the factory entity itself. I may also ask for the production license or relevant audit documentation depending on the destination market and buyer requirements. The objective is not to collect certificates for decoration; it is to understand who is legally and operationally responsible for the batch. A factory that can provide clear, current documents linked to the actual manufacturing entity gives me much more confidence than one that only shows cropped certificate images with no obvious connection to the supplier or production site.

Confirm Export Documentation

For international projects, I want to confirm the documentation package before the formula is finalized because missing files can delay launch even when the product itself is already manufactured. Depending on the project, I may need the full INCI, finished-product COA, SDS or MSDS, product specification, microbiological or stability information, Certificate of Free Sale, transportation reports, batch-related records, or other technical files required by the buyer, platform, customs process, or local compliance partner. For EU and UK projects, I also want to know what information the factory can provide to support CPSR, PIF, label preparation, and responsible-person review, while recognizing that the manufacturer does not replace the brand owner’s legal obligations. I prefer to clarify this scope before placing the order because “compliance support” can mean very different things from one supplier to another. One factory may provide a complete technical dossier, while another may only provide an ingredient list and COA, so the buyer needs to understand exactly what is included.

Separate Formula MOQ From Packaging MOQ

MOQ is rarely one single number in a private-label project, which is why I always separate the minimum quantity for the formula from the minimum quantity for packaging and decoration. A factory may be able to produce 1,000 units of a serum, but the bottle supplier may require 3,000 pieces, the printed carton may have a different minimum, and a custom mold or special decoration process may require 5,000 or more. This becomes particularly important for small and growing brands because packaging can easily become the factor that pushes a project beyond the intended budget. I therefore ask for the MOQ of the bulk formula, primary packaging, pumps or closures, labels, cartons, and any decorative process separately, as well as whether unused components can be stored for the next production run. When these numbers are clear at the beginning, I can make a more realistic decision about whether to use stock packaging for the first launch or invest in a fully custom package once sales are proven.

Confirm Sample and Production Lead Times

Finally, I look at lead time as a sequence rather than one promised number. A supplier may say production takes 20 days, but that usually begins only after the formula, packaging, artwork, payment, and sometimes testing are fully approved. Before scheduling a launch, I want to understand how long initial sampling takes, how quickly revisions can be made, whether stability observation is needed, how long custom packaging requires, when bulk formula production can begin, how much time is needed for filling and assembly, and whether final inspection or export preparation adds additional days. I also ask what happens if the sample needs another revision or if a packaging component is delayed, because those are common real-world situations. A manufacturer that gives me a realistic timeline with clear stages is much more useful than one that promises an unusually short lead time without explaining what is included. For e-commerce and retail brands, accurate timing is part of supply-chain reliability, and I would rather plan around a realistic production schedule than build a launch around a date that the factory cannot consistently meet.

Ready Formula vs Custom PDRN Formula

When buyers ask me whether they should choose a ready formula or develop a custom PDRN product, I rarely treat it as a simple question of quality. The better choice depends on the brand’s stage, launch timing, budget, technical requirements, and how much differentiation is commercially necessary. A ready formula can be the smarter decision for a distributor or e-commerce seller that needs to enter the market quickly, while a fully custom formula makes more sense for an established brand that already knows exactly how the product should feel, perform, and fit into a larger product system. In between those two options is semi-custom development, which in many real projects offers the best balance between speed, risk, and differentiation. From our experience at Metro Private Label, the most successful projects usually begin by matching the development model to the buyer’s business reality rather than assuming that more customization is always better.

Ready Formula

A ready formula is usually the most practical option when the priority is speed, lower development cost, and reduced technical risk. This model is especially suitable for distributors, retailers, first-stage e-commerce brands, or businesses that want to test whether PDRN can sell in their existing channel before committing to a larger development program. The main advantage is that the base formula has already gone through internal development and is typically closer to commercial production, which means sampling can move faster and fewer formulation revisions are required. For a buyer launching a PDRN serum, cream, toner, or mask quickly, this can significantly shorten the time between supplier selection and finished inventory. It also reduces the cost of repeated R&D work and lowers the risk that a complex custom brief will create delays around stability, preservation, or packaging compatibility. The trade-off is that the formula may be less distinctive, so I usually see ready formulas as strongest when the business model depends more on channel strength, packaging, pricing, and launch speed than on proprietary formulation.

Semi-Custom Formula

Semi-custom development is often the option I recommend most strongly for growing brands because it allows the buyer to start from a stable, commercially proven formula and adjust the areas that matter most to the brand. Depending on the project, that may involve changing the PDRN positioning, modifying the supporting active system, adjusting texture or viscosity, removing or adding fragrance, refining skin feel, or selecting a packaging format that better matches the target price point and market positioning. This approach usually creates a better commercial balance because the buyer gains meaningful differentiation without taking on the full cost, timeline, and technical uncertainty of building a formula entirely from zero. For example, an e-commerce brand may begin with an existing PDRN serum base but add peptides, ectoin, ceramides, or a different humectant system to create a more specific repair or anti-aging story, while a clinic may prefer a lighter, fragrance-free version with professional airless packaging. From our perspective at Metro Private Label, this middle path is often the most realistic for buyers who already understand their market and want a product that feels more proprietary but still needs to launch within a manageable budget and timeline.

Fully Custom Formula

A fully custom PDRN formula makes the most sense when the brand already has clear positioning, defined technical expectations, a larger development budget, and a long-term reason to create something that cannot be easily replicated through a stock formula. These projects usually involve more detailed decisions around the PDRN raw material, concentration basis, supporting actives, preservation strategy, texture, pH, delivery system, packaging compatibility, claims direction, and target-market requirements. The development process is naturally longer because each change can affect the rest of the formula, and the buyer should expect more sampling rounds, more testing, and potentially more packaging evaluation before production is approved. I usually see this model as most appropriate for established skincare brands, experienced beauty founders, or professional channels that already know what they want the product to achieve and have enough commercial scale to justify the additional investment. The benefit is stronger differentiation and greater control over the final product, but the project only makes sense when the brand has a clear reason for that complexity. A fully custom formula should solve a real positioning or performance requirement, not simply exist so the brand can say that the product is custom.

What PDRN Skincare Products Can Chinese Manufacturers Produce

When buyers first approach a Chinese manufacturer about PDRN, they often begin with a serum because it is the most obvious hero product, but the category is now much broader than that. Chinese OEM and ODM factories can develop PDRN into serums, creams, eye care, toners, toner pads, masks, mists, and complete skincare systems, and the right choice depends heavily on how the brand plans to sell. An Amazon operator may need a visually clear hero SKU with strong search demand, a distributor may prefer several ready-to-label products that can be sold as a range, while a clinic may care more about professional-looking repair products that can be recommended alongside treatments. From our perspective at Metro Private Label, the product format should therefore be selected together with the sales channel, target retail price, packaging, repeat-purchase logic, and how much education the end customer will need before buying.

PDRN Serum

PDRN serum is still the most straightforward commercial entry point for many brands because consumers already understand serum as an active-led skincare format, which makes the ingredient story easier to communicate on Amazon, Shopify, TikTok Shop, and other e-commerce channels. For a new or growing brand, I often see serum as the most practical first SKU because it can support a premium ingredient narrative without requiring a complicated routine, while the 30 ml format also gives buyers a relatively familiar cost and packaging structure. The main decision is not simply whether to make a PDRN serum, but what type of serum the channel actually needs: a lightweight daily formula for mass e-commerce, a peptide and PDRN anti-aging concept for a more premium DTC brand, or a fragrance-free repair serum for a clinic or sensitive-skin range. Serums also give manufacturers more flexibility to combine PDRN with niacinamide, peptides, ectoin, hyaluronic acid, panthenol, ceramides, or other supporting actives, which can help the product avoid becoming another generic “PDRN serum” competing only on percentage and price.

PDRN Repair Cream

PDRN repair cream makes more sense when the brand wants to build repeat purchase and daily-routine use rather than rely only on one high-interest hero serum. For beauty founders and clinics, I often see the cream as commercially valuable because it can be positioned around barrier support, comfort, and long-term use, which makes it easier to connect with sensitive-skin, anti-aging, or post-treatment routines. A cream also gives the manufacturer more room to build a richer supporting system around ceramides, squalane, panthenol, beta-glucan, peptides, and emollients, but it usually requires more attention to texture, emulsification, packaging, and climate suitability than a simple water-based serum. For distributors, PDRN cream can work well as the second SKU after serum because it creates a clearer two-step routine and raises the average order value, while for clinics it can become the more practical home-care product that clients continue using between appointments.

PDRN Eye Serum and Eye Cream

PDRN eye serum and eye cream are more suitable for brands that want to raise perceived value or build a premium range rather than launch the widest possible mass-market product. The eye-care category allows a brand to combine PDRN with peptides, caffeine, hyaluronic acid, ceramides, or other ingredients associated with firmness, hydration, and a more targeted routine, and the smaller pack size can support a higher unit retail price without making the product look overly expensive. I would see this format as particularly relevant for aesthetic clinics, premium DTC brands, and beauty founders who already have a core facial serum or cream and want a logical extension rather than another unrelated SKU. For distributors, eye care can also help create a more complete shelf presentation, but it generally works better as part of an established range than as the first PDRN product a buyer uses to test market demand.

PDRN Toner and Essence

PDRN toner and essence are useful for brands that want to build a layered skincare routine, especially in markets where Korean-style multi-step skincare is already familiar to consumers. From a commercial perspective, these formats are usually easier to position as hydration and preparation products rather than as the most concentrated treatment step, which means they work well as supporting SKUs around a serum and cream. A distributor may find toner particularly useful because it gives the brand a lower-cost entry product and helps create a coordinated PDRN line across several price points, while a DTC brand can use an essence to build a more premium or biotech-inspired routine. From the manufacturing side, these products may look simple, but the formula still needs to maintain clarity, skin feel, preservative stability, and compatibility with the chosen bottle or pump, especially if the brand wants a milky toner or more complex essence rather than a basic watery base.

PDRN Toner Pads

PDRN toner pads make particular sense for TikTok-driven brands, younger e-commerce audiences, and distributors that want a product with stronger visual and usage differentiation than a conventional toner bottle. The format is easy to demonstrate in short-form video, can be positioned around daily convenience, and gives the brand more opportunities to combine PDRN with Centella, niacinamide, peptides, or soothing actives. I also see toner pads as commercially useful because they sit between skincare and treatment behavior: consumers can understand them quickly, but the product still feels more distinctive than a standard liquid toner. The manufacturing challenge is more complex than it appears, because the fabric, essence loading, pad count, container seal, moisture retention, preservative system, and leakage risk all need to be controlled together. For brands that mainly compete through content and visual merchandising, however, toner pads can be one of the more effective formats for turning PDRN into something that looks and behaves differently from another serum.

PDRN Facial Masks and Hydrogel Masks

PDRN facial masks and hydrogel masks are especially relevant for distributors, clinics, salons, gift sets, and promotional programs where a one-time treatment format is easier to sell than a complete daily routine. Sheet masks allow buyers to create a relatively accessible PDRN product with strong visual branding and a simple usage story, while hydrogel masks can support a more premium, professional, or clinic-adjacent image. From our experience as a manufacturer, the commercial appeal is strong because masks can be sold individually, in multi-piece boxes, or combined with serums and creams in kits, but the production structure is different from bottled skincare. MOQ is often driven by mask substrate, pouch printing, tray or mold format, essence loading, and outer-box quantities rather than only the formula itself. Clinics may use PDRN masks as a home-care or treatment-support product, while e-commerce brands can use hydrogel formats to create stronger visual content and higher perceived value, especially when the packaging and mask structure are distinctive.

PDRN Mists

PDRN mists are better suited to brands that want a lightweight, portable, and high-frequency-use product rather than a traditional concentrated treatment. I would not normally choose a mist as the first PDRN SKU unless the brand already has a strong content or lifestyle concept, but it can work well as an extension product for e-commerce, travel, clinic aftercare, or beauty routines where convenience matters. The commercial advantage is that mists are easy to demonstrate, easy to reapply, and can be positioned around hydration, soothing, or refreshing use, but the formula must be low enough in viscosity to spray evenly and the pump system must produce the right droplet size without clogging or leaking. For distributors, mists can add variety to a PDRN range; for clinics, they may function as a gentle support product; and for social-commerce brands, they can become a visually appealing SKU when the packaging and usage experience are strong enough to justify the format.

PDRN Skincare Sets

A complete PDRN skincare set makes the most sense when the buyer already has a sales channel, enough budget to support multiple SKUs, and a clear reason to sell a routine rather than one hero product. For a distributor, this could mean toner, serum, cream, and mask sold as a coordinated range; for a clinic, it might be a repair serum, barrier cream, and mask designed around home-care use; and for an experienced DTC founder, the set can create stronger brand architecture and increase average order value. I would be more cautious recommending a full set to a first-time brand with no sales history because launching five or six products at once increases inventory, packaging, testing, and cash-flow pressure before the buyer knows which SKU customers actually want. From our perspective at Metro Private Label, the most practical approach is often to begin with one or two hero products, confirm market response, and then extend into a wider PDRN system once there is evidence of repeat demand. This is usually more commercially sustainable than building a large range simply because the factory is technically able to manufacture it.

How Much Does Private Label PDRN Skincare Cost in China

When buyers ask me how much a private label PDRN serum costs in China, I usually avoid giving one universal number because the final price depends on far more than the bottle size. Two 30 ml PDRN serums can look almost identical in a product photo and still receive very different quotations because the raw material, active level, supporting ingredients, formula complexity, packaging, decoration, testing, documentation, and order quantity may all be different. From our perspective at Metro Private Label, the more useful way to understand cost is to break the quotation into its main components and then compare suppliers on the same basis. A lower unit price may reflect a simpler formula, more standard packaging, fewer included documents, or a larger MOQ, while a higher quotation may include a more expensive PDRN source, custom actives, premium airless packaging, extra testing, and more complete export support. Without understanding what is included, comparing only the final unit price can easily lead to the wrong sourcing decision.

PDRN Raw Material and Active Level

The PDRN raw material itself can create a meaningful price difference because not every supplier is using the same ingredient source, specification, concentration, or format. One factory may use a diluted Sodium DNA solution supplied at a lower raw-material cost, while another may work with a higher-specification material that comes with stronger traceability, COA documentation, or a more defined concentration basis. The active level also matters, but I do not compare it simply by the percentage shown on the quotation. A formula using 1% of a premixed complex may not contain more meaningful active than another formula using a lower percentage of a more concentrated material. This is why I prefer to compare the raw-material specification, supplier information, addition level, and finished-formula basis together. In a premium PDRN serum, the cost difference often begins here, long before packaging is added.

Supporting Actives and Formula Complexity

The rest of the formula can have just as much impact on cost as the PDRN itself. A basic hydrating serum built around PDRN, glycerin, and hyaluronic acid will usually cost less than a more complex formula combining PDRN with peptides, ectoin, ceramides, niacinamide, panthenol, bakuchiol, collagen-related ingredients, or multiple molecular weights of hyaluronic acid. The preservative system, texture, pH adjustment, emulsification method, and sensitivity positioning can also change development cost and raw-material cost. If the buyer asks for fragrance-free, phenoxyethanol-free, silicone-free, or other formulation restrictions, the manufacturer may need to redesign parts of the system rather than simply remove one ingredient. From a sourcing perspective, this is why two serums with the same hero claim can have different cost structures even when both are sold as “PDRN repair serum.”

Packaging Can Change the Quotation More Than Buyers Expect

Packaging is often one of the largest variables in a private label quotation, especially for premium PDRN products where the buyer wants the finished product to look more clinical, biotech, or high-end. A standard stock dropper bottle with a printed label may be relatively inexpensive, while a custom airless pump, heavy-wall bottle, metallized component, special cap, silk-screen printing, hot stamping, or custom-colored component can increase the unit cost quickly. Packaging also has its own MOQ, which may be higher than the formula MOQ. A factory may be willing to produce 1,000 bottles of serum, but the preferred bottle supplier may require 3,000 or 5,000 pieces for a custom color or decoration process. I therefore always look at the formula price and packaging price separately before deciding whether a quotation is truly more competitive.

Printing and Cartons Add Another Layer of Cost

Labels, silk-screen printing, UV printing, hot stamping, cartons, inserts, shrink film, and outer-case requirements all add cost that is easy to overlook when comparing quotations from different factories. One supplier may quote only the filled bottle, while another includes a retail carton, barcode label, batch coding, shrink wrapping, and export carton. That can make the second quotation appear more expensive even though it is actually more complete. For e-commerce brands, I also think about whether the packaging is strong enough for fulfillment and shipping because a cheaper carton or poorly protected bottle can create leakage, breakage, and negative reviews later. From my perspective, packaging cost should therefore be evaluated together with commercial risk rather than treated only as decoration.

Testing and Documentation Can Affect the Total Project Budget

Testing is another area where buyers often assume everything is included in the unit price, but that is not always the case. A ready formula may already have basic stability and microbiological data, while a customized PDRN formula may require new stability observation, compatibility testing, challenge testing, or additional market-specific documentation. Depending on the project, the buyer may also need COA, SDS, full INCI, product specifications, microbiological reports, Certificate of Free Sale, transport reports, or documents to support CPSR, PIF, platform review, or local compliance. These costs may be charged separately or included only at certain order quantities. I prefer to clarify this before the sample stage because a quotation that looks cheaper at first can become more expensive once the buyer adds testing and documentation that another manufacturer already included.

MOQ and Production Quantity Change the Unit Cost

Order quantity has a direct impact on cost because raw-material purchasing, filling, packaging setup, printing, labor, and quality-control work all need to be spread across the production run. A 1,000-unit test order usually carries a higher unit cost than 5,000 or 10,000 units because the same setup work is divided across fewer finished products. This is why low MOQ is commercially useful but rarely the cheapest option on a per-unit basis. For growing brands, I usually see the best decision as balancing inventory risk against unit cost rather than chasing the lowest possible price. A 10,000-unit quotation may look attractive, but if the brand can only sell 2,000 units in the first few months, the extra inventory becomes more expensive than the savings. For that reason, production quantity should be chosen according to realistic sales velocity and repeat-order planning, not only factory pricing.

Why Two 30 ml PDRN Serums Can Have Very Different Prices

A simple example explains the difference clearly. One 30 ml serum may use a ready formula, standard Sodium DNA material, basic hyaluronic acid support, stock dropper packaging, a printed label, and a 5,000-unit order with minimal customization. Another 30 ml serum may use a more expensive PDRN raw material, a higher-specification peptide and ectoin system, a phenoxyethanol-free preservative strategy, a custom airless bottle, silk-screen printing, an individual carton, additional stability work, and a 1,000-unit launch quantity. Both products may be described online as “30 ml PDRN serum,” but they are not commercially equivalent. From our perspective at Metro Private Label, the only meaningful way to compare quotations is to align the raw material, formula specification, packaging, decoration, testing, documentation, and quantity first. Once those variables are the same, the unit price becomes much more useful as a sourcing decision.

China vs Korea for Private Label PDRN Skincare

When buyers ask me whether China or Korea is the better place to manufacture private label PDRN skincare, I do not think there is a useful one-word answer. The two sourcing markets solve different commercial problems. Korea has a strong connection with K-beauty, aesthetic skincare, and the consumer story surrounding PDRN, which can add value when country of origin is part of the product positioning. China, on the other hand, has developed a highly integrated cosmetics manufacturing and packaging supply chain that can be particularly attractive when a brand needs flexibility across formula, bottle, pump, carton, decoration, MOQ, and future SKU expansion. From our perspective at Metro Private Label, I would make the decision based less on which country appears more prestigious and more on what the brand actually needs to sell: the target retail price, market positioning, product specification, initial quantity, packaging expectations, sales channel, and whether the origin itself will influence the customer’s willingness to buy.

Why Brands Consider Korea

Korea is naturally attractive to PDRN brands because PDRN fits closely with the wider consumer perception of Korean aesthetic skincare, regenerative beauty, intensive hydration, skin-repair routines, and ingredient-led K-beauty innovation. For a brand selling through premium DTC, beauty boutiques, aesthetic clinics, or channels where “Made in Korea” carries meaningful consumer recognition, the manufacturing origin can become part of the product story rather than remaining a supply-chain detail hidden on the back label. This is particularly relevant when the brand wants PDRN to feel connected to Korean skincare culture rather than simply use it as another active ingredient. A Korean manufacturing partner may therefore make commercial sense even when the unit cost is not the lowest option, because the brand is also purchasing an origin story that can support packaging, advertising, influencer content, and premium positioning. I would still evaluate the manufacturer in the same way I would evaluate any other supplier, including raw-material documentation, concentration basis, formula stability, MOQ, testing, and packaging compatibility, because “Made in Korea” does not automatically make one PDRN formula technically better than another. The advantage is strongest when Korean origin has genuine value to the end customer and the brand knows how to communicate that value through its sales channel.

Why Brands Consider China

China becomes particularly attractive when the buyer needs more flexibility across the entire private-label project rather than only the formula. In places such as Guangzhou and the wider Pearl River Delta cosmetics supply chain, skincare manufacturing sits very close to bottle suppliers, pump manufacturers, label printers, carton factories, decoration vendors, mold suppliers, and export-service companies, which can make product development more integrated when several components need to change at the same time. From our experience at Metro Private Label, this matters because a PDRN project often evolves during sampling: the buyer may want to change the serum viscosity, move from a dropper to an airless pump, adjust the bottle color, revise the carton, add a peptide or ceramide combination, or begin with standard packaging at 1,000 units before investing in a more customized component at a larger volume. Chinese OEM/ODM manufacturing can be commercially attractive in these situations because buyers often have a wide choice of existing packaging, different customization levels, broad supporting-active options, and the ability to develop several related SKUs through the same supply chain. This does not mean China is automatically the lowest-cost option or that every Chinese factory offers the same flexibility, but for e-commerce brands, growing beauty companies, distributors, and clinics that need to control initial investment while still leaving room for product iteration, the combination of manufacturing and packaging infrastructure can be a significant advantage.

Which One Should You Choose

I would choose between China and Korea by starting with the brand’s business model rather than the ingredient trend. If Korean origin will be visible on the front end of the business and helps justify a premium retail price, supports a K-beauty story, strengthens clinic positioning, or matches what the existing customer base already expects, then paying more or accepting a different MOQ structure for Korean production may be commercially justified. If the brand is primarily competing through Amazon, Shopify, TikTok Shop, distribution, or its own brand identity rather than country-of-origin marketing, China may offer more practical room to balance formula customization, packaging choice, production quantity, cost, and faster SKU iteration. I would also consider how technically defined the project already is: a brand with a strict PDRN specification and proprietary development brief should compare individual R&D teams rather than countries, while a buyer that needs a serum, cream, eye product, mask, and packaging system developed together may benefit more from an integrated OEM/ODM ecosystem. In the end, I do not see this as China versus Korea in terms of which country makes “better PDRN.” The better choice is the manufacturing market that supports the brand’s positioning, MOQ, budget, formula requirements, packaging strategy, sales channel, and long-term plan without forcing the business to pay for an advantage its customers do not actually value.

Common Mistakes Buyers Make When Sourcing PDRN Skincare

When I look at the PDRN projects that become difficult, the problems usually do not start with the ingredient itself. They start with how the buyer compares suppliers, interprets technical information, selects packaging, or plans the launch. PDRN is now a highly marketable skincare concept, which means buyers are often presented with strong percentages, premium ingredient stories, attractive packaging, and very different quotations that can look difficult to compare. From our perspective at Metro Private Label, the most useful sourcing discipline is to slow down before production and make sure the raw material, formula system, packaging, compliance scope, and commercial plan all make sense together. The mistakes below are common because they often look harmless at the quotation stage, but they can become expensive once sampling, bulk production, or market launch has already started.

Choosing the Factory With the Highest PDRN Percentage

One of the most common mistakes I see is assuming that the factory offering the highest PDRN percentage must also be offering the strongest or most premium formula. That comparison is only meaningful if both suppliers are using the same raw material, the same concentration basis, and the same method of expressing the percentage. One manufacturer may quote 1% of a diluted PDRN complex, while another may use a lower addition level of a more concentrated Sodium DNA material, which means the headline numbers are not directly comparable. I therefore prefer to ask what the percentage represents, what the raw-material specification is, what the COA says, and how much of the supplied material is actually added to the finished formula. A higher number can be commercially attractive, but without the underlying technical basis it may tell the buyer more about marketing than about the real formulation value.

Assuming Salmon DNA and Every PDRN Ingredient Are the Same

Another mistake is treating salmon DNA, Sodium DNA, PDRN, plant-derived DNA ingredients, and supplier-specific nucleic-acid complexes as though they were interchangeable. In real sourcing, these terms can refer to materials with different origins, specifications, concentrations, carrier systems, and documentation. A buyer may see “salmon PDRN” on one quotation and “Sodium DNA” on another and assume the first one is automatically more authentic or more effective, but the commercial name alone does not tell the full story. I want to know the INCI, raw-material source, supplier specification, COA, concentration basis, and how the ingredient is intended to be used in the formula. The practical sourcing lesson is simple: if two suppliers cannot clearly explain what material they are using, I would not compare their products as though they are technically equivalent.

Selecting Packaging Before Formula Testing

Packaging is often chosen too early because buyers naturally want to see how the finished product will look, but I prefer to confirm the formula direction before locking the bottle or pump. A beautiful airless bottle can still be the wrong choice if the serum is too thick, the pump output is inconsistent, or the formula interacts poorly with the component materials over time. The same applies to droppers, jars, tubes, and mist pumps. For PDRN products, I also consider air exposure, dosage, viscosity, leakage risk, and the amount of product that remains trapped inside the package. From a manufacturing point of view, the formula and packaging need to be tested as one system. Selecting packaging too early can force unnecessary reformulation later, increase development cost, or create a finished product that looks premium but performs poorly in real consumer use.

Comparing Quotations Without Checking What Is Included

Two quotations can look easy to compare when both show a unit price, but the scope behind that number may be completely different. One factory may include the formula, bottle, pump, label, retail carton, batch coding, filling, and export carton, while another may quote only the filled bottle and charge separately for packaging development, testing, printing, or documentation. I always try to compare suppliers on the same basis before deciding which one is truly more competitive. This means looking at raw material, formula, packaging, decoration, testing, documentation, MOQ, and production quantity together. A lower price is not always a better deal if the buyer still needs to add several missing costs later, and a higher quotation may actually be more complete and easier to manage. The safest comparison is not “Which supplier is cheaper?” but “Which supplier is quoting the same project scope?”

Assuming ISO 22716 Automatically Makes a Product Market-Compliant

ISO 22716 is an important manufacturing standard, but I do not treat it as proof that a finished PDRN product is automatically compliant in every market. The certification relates to cosmetic Good Manufacturing Practice, while market compliance depends on the formula, ingredient restrictions, labeling, safety assessment, claims, responsible-person requirements, product notification, and other local obligations. For example, a factory can operate under ISO 22716 and still produce a formula that requires changes before it is suitable for the EU, UK, US, or another destination market. From our perspective at Metro Private Label, I see ISO 22716 as one part of supplier qualification, not a substitute for product-specific compliance work. Buyers should still confirm the INCI, documentation, claims, target-market requirements, and what support the manufacturer can provide for local regulatory preparation.

Using Medical or Injectable PDRN Claims on Cosmetic Products

PDRN has strong associations with aesthetic medicine, injectable treatments, and regenerative procedures, which creates a real marketing risk for cosmetic brands. I often see buyers wanting to use language such as “regenerates tissue,” “repairs damaged DNA,” “heals skin,” or directly reference injectable PDRN treatments because those claims sound more powerful. The problem is that a topical cosmetic product is not regulated in the same way as an injectable or medical treatment, and claims that imply treatment, healing, or physiological modification may create regulatory and advertising problems depending on the market. I therefore prefer to separate the consumer interest around medical-aesthetic PDRN from what the finished cosmetic formula can actually and legally claim. A strong PDRN skincare product does not need to imitate injectable language to be commercially attractive; it needs a clear cosmetic positioning that is supported by the formula, documentation, and the rules of the destination market.

Launching Too Many PDRN SKUs Before Testing Demand

The final mistake I see frequently is launching an entire PDRN line before the brand has any real sales data. A manufacturer may be able to offer serum, cream, toner, eye care, masks, toner pads, and mists, but that does not mean a new brand should produce all of them at once. Every additional SKU adds formula cost, packaging MOQ, artwork, testing, inventory, and cash-flow pressure, while the buyer still does not know which product customers will actually repurchase. In many cases, I would rather see a brand begin with one or two hero products, such as a serum and repair cream, confirm demand, and then expand into masks, eye care, or toner pads once the first products have proven themselves. From a commercial perspective, a smaller launch usually gives the buyer clearer data and reduces risk, while still leaving room to build a complete PDRN range later if the market responds well.

Questions to Ask Every PDRN Manufacturer Before Requesting Samples

Before I request a sample, I prefer to ask enough questions to understand whether the manufacturer is actually suitable for the project, because sampling should confirm a promising supplier rather than become the first time I discover basic technical and commercial information. A good PDRN sample can look impressive, but if the raw material is unclear, the quoted percentage is ambiguous, the packaging MOQ is too high, or the required documents are unavailable, the project may still fail before production. From our perspective at Metro Private Label, the most useful questions are the ones that reveal how the supplier thinks about the raw material, formula system, customization, MOQ, testing, documentation, and production timeline. The goal is not to interrogate the factory; it is to make sure both sides are discussing the same product before time and money are invested in development.

What PDRN Raw Material Do You Use

The first question I would ask is, “What PDRN raw material do you use?” because the answer sets the technical foundation for everything that follows. I want the manufacturer to explain whether the formula uses Sodium DNA, salmon-derived PDRN, a plant-derived or vegan-positioned alternative, or a supplier-specific complex, and I want that explanation to match the technical documents rather than exist only in sales language. A supplier that can identify the material clearly usually makes the rest of the discussion much easier because concentration, cost, claims, and stability can then be evaluated on a real basis. If the answer remains vague, such as “high-quality Korean PDRN” or “premium salmon DNA” without any usable specification, I would not treat that as enough information for a serious sourcing decision.

What Is the INCI Name

The next question is, “What is the INCI name of the PDRN-related ingredient?” because the commercial name and the label name may not be the same. A product may be marketed as PDRN skincare while the actual INCI lists Sodium DNA or another ingredient designation, and that distinction matters for technical review, label preparation, and market compliance. I want to know exactly how the material will appear in the finished ingredient list and whether that naming is consistent across the formula sheet, supplier specification, and supporting documentation. This also helps avoid confusion when a buyer compares two factories that use different marketing terms for materials that may or may not be technically equivalent.

Can You Provide the Raw-Material COA

I would then ask, “Can you provide the raw-material COA?” because the COA is one of the most practical ways to move the discussion from marketing into verifiable technical information. The document can help confirm the ingredient identity, batch information, specification, and quality parameters associated with the material being proposed. Depending on the supplier, I may also ask for a specification sheet, SDS, origin information, or other supporting documents. I do not expect every buyer to become a raw-material specialist, but I do expect a manufacturer working with premium active ingredients to be able to support its ingredient story with documentation that can be reviewed by the brand, regulatory consultant, or product-development team.

What Does Your Quoted PDRN Percentage Represent

One of the most important questions is, “What does your quoted PDRN percentage represent?” because a percentage without a concentration basis can be misleading. I want to know whether the number refers to the amount of a raw-material solution added to the formula, the concentration of Sodium DNA within that solution, or a defined active level in the finished product. This is essential when comparing quotations because a factory offering 1% PDRN may not actually be providing a higher active basis than another factory quoting 0.5%. If the supplier can explain the percentage clearly and support it with the raw-material specification, I can compare the formula more meaningfully. If the number cannot be explained, I treat it as a marketing figure rather than a technical specification.

Can You Customize the PDRN Concentration

I also ask, “Can you customize the PDRN concentration?” but I am equally interested in how the manufacturer responds. A strong formulation team should not simply say that any percentage is possible. I want to understand the practical range, how the raw-material specification affects that range, whether higher addition levels change viscosity, pH, preservation, cost, or stability, and whether the proposed concentration makes sense for the target product and market. In my experience, a useful supplier explains the trade-offs rather than treating concentration as a number that can be increased indefinitely. This is especially important for brands that want differentiation but still need the formula to remain commercially stable and economically realistic.

What Supporting Actives Do You Recommend

The question “What supporting actives do you recommend?” tells me a lot about the manufacturer’s product-development capability. A supplier that understands the project should be able to suggest combinations based on the positioning the brand wants to create, such as peptides for a premium anti-aging concept, ceramides and panthenol for barrier support, ectoin or Centella for a more sensitive-skin direction, or hyaluronic acid for hydration. I do not expect every factory to propose the same formula, but I do want to see whether the recommendations are commercially and technically coherent rather than simply adding as many trending ingredients as possible. From our perspective at Metro Private Label, the supporting active system should help create a clear product story while still respecting stability, skin feel, cost, and the intended sales channel.

What Is the Formula MOQ

I would ask, “What is the formula MOQ?” because the minimum batch for the actual product is not always the same as the minimum quantity shown on the manufacturer’s website. A ready PDRN serum may be available from 500 or 1,000 units, while a custom formula may require 2,000, 3,000, or more depending on the production vessel, raw-material procurement, and development scope. I also want to know whether the MOQ applies to one SKU, one fragrance, one texture, or one complete formula variation. This matters for buyers planning several PDRN products because a 1,000-unit MOQ per SKU can quickly become a much larger inventory commitment when serum, cream, toner, and mask are all launched together.

What Is the Packaging MOQ

I always separate the next question: “What is the packaging MOQ?” because packaging often becomes the real constraint in a private-label project. The formula may be possible at 1,000 units while the bottle supplier requires 3,000 pieces for a custom color, 5,000 for a special pump, or more for a custom mold or decoration process. I want to know the MOQ for the bottle, pump, label, carton, and any special printing separately so I can see where the real commercial commitment sits. For a test launch, stock packaging with custom labels may make more sense, while a proven brand can justify a larger quantity for custom decoration. Clarifying this before samples prevents the buyer from approving a beautiful package that later forces the order far beyond the original budget.

What Documents Can You Provide

Another question I consider essential is, “What documents can you provide for this specific product?” because general statements such as “we support EU and US compliance” are too broad to evaluate. I want to know whether the supplier can provide the full INCI, finished-product COA, SDS or MSDS, product specifications, raw-material documentation, microbiological reports, stability information, Certificate of Free Sale, transportation reports, or other files required for the project. For UK and EU brands, I also want to know what information the factory can provide to support CPSR, PIF, and label review, while understanding that the manufacturer does not replace the responsible person or local regulatory obligations. The important point is to confirm the actual document package before production rather than discover after filling that a key file is unavailable.

What Testing Is Included

I would also ask, “What testing is included in the quotation?” because testing can vary significantly between manufacturers and between ready and custom formulas. A stock formula may already have stability or microbiological data, while a new custom PDRN formula may require fresh stability observation, packaging-compatibility testing, microbial testing, or preservative challenge testing. I want to know which tests are standard, which are optional, which are charged separately, and how long each test may affect the project timeline. This is particularly important when the buyer requests unusual active levels, preservative restrictions, or new packaging, because those changes can make previous testing less relevant. A manufacturer that explains the testing scope clearly gives me much more confidence than one that simply says the formula is “stable” without showing how that conclusion was reached.

What Is the Sample Lead Time

The question “What is the sample lead time?” should be answered with enough detail to show what the supplier means by a sample. A ready formula may be available within a few working days, while a semi-custom or fully custom formula can take longer because the R&D team needs to adjust actives, texture, fragrance, pH, preservation, or packaging compatibility. I also ask how long revisions take and whether the quoted timeline includes packaging samples or only the formula itself. This matters because a buyer may hear “seven-day sample” and assume the complete branded package will be ready in one week when the supplier is actually referring only to a small laboratory bottle. The more clearly the manufacturer separates formula sampling, revisions, packaging sampling, and approval, the easier it is to build a realistic launch plan.

What Is the Production Lead Time

I then ask, “What is the production lead time after sample approval?” and I want the answer broken into realistic stages rather than one optimistic number. Bulk formula production, packaging manufacturing, printing, filling, assembly, quality inspection, and export preparation may all have different timelines, and the slowest component often determines the final delivery date. A standard bottle with an existing formula may move relatively quickly, while custom packaging or new testing can extend the schedule significantly. I also want to understand whether the lead time begins after deposit, after artwork approval, after packaging arrival, or after final formula confirmation. For e-commerce and retail buyers, this question is critical because replenishment reliability can affect rankings, promotions, and customer retention just as much as the quality of the first batch.

Which Markets Do You Currently Export To

Finally, I ask, “Which markets do you currently export PDRN or similar skincare products to?” because practical export experience can reveal whether the manufacturer is familiar with the documentation, labeling, and commercial expectations of the buyer’s target region. A supplier that already works with customers in the EU, UK, US, Canada, Middle East, or other regulated markets is more likely to understand the kinds of questions that arise around ingredient lists, claims, certificates, product notifications, and shipping documents. I would not assume that export experience automatically makes every formula compliant, but it can reduce communication friction and help identify problems earlier. For me, the most useful answer is not simply “we export worldwide,” but a clear explanation of where similar products have been shipped and what support the manufacturer typically provides for those markets.

Why These Questions Matter Before Sampling

The reason I ask these questions before requesting samples is simple: a sample should confirm product direction, not hide unresolved sourcing problems. If the supplier can clearly explain the PDRN raw material, percentage basis, supporting actives, MOQ, packaging, documents, testing, and timeline before sampling begins, the project is much more likely to move efficiently once the physical sample is approved. From our perspective at Metro Private Label, this is also the stage where a buyer can judge the quality of the manufacturer’s communication. A strong supplier does not only answer “yes” or “no”; it explains what is possible, what needs verification, and where the project may create technical or commercial trade-offs. That transparency is often more valuable than an unusually fast quotation.

How to Build Your Final Three-Supplier Shortlist

Once I have reviewed a long list of PDRN manufacturers, I do not think the next step should be sending the same vague message to all twelve companies. That usually produces twelve quotations that are difficult to compare because each supplier interprets the project differently. One may quote a ready serum, another may assume a custom formula, one may include packaging, and another may quote bulk formula only. From our perspective at Metro Private Label, the more effective approach is to narrow the list first, prepare a short but specific RFQ, and then ask the final three suppliers to respond to the same commercial and technical brief. This makes the comparison much more meaningful and helps the buyer move through the sourcing process in a logical sequence: search, compare, verify, and then sample.

Do Not Send the Same Vague Inquiry to All 12 Manufacturers

A message such as “I want to make a PDRN serum, please send your price and MOQ” may look efficient, but it gives the manufacturer too much room to make assumptions. One supplier may think the buyer wants a standard 30 ml serum in stock packaging, while another may assume a custom airless bottle, a more expensive raw material, or a formula built around peptides and ceramides. The result is that the buyer receives prices that look comparable but are actually based on different products. I prefer to remove that uncertainty before asking for a quotation. By the time the shortlist reaches three suppliers, the project should already be defined well enough that each manufacturer is answering the same question rather than inventing its own version of the product.

Prepare a Short RFQ That Explains the Project Clearly

The RFQ does not need to be a long technical document, but it should give the manufacturer enough information to understand the commercial direction. I would clearly state the product type, whether it is a serum, cream, mask, toner, or another format, and include a benchmark product if there is one so the supplier can understand the desired texture, packaging level, and market positioning. I would also specify the target market, expected first-order quantity, desired PDRN positioning, any supporting actives such as peptides, ceramides, niacinamide, ectoin, or hyaluronic acid, and whether the project should use ready, semi-custom, or fully custom development. Packaging preference, target launch date, and budget positioning are equally important because they help the factory decide whether a standard bottle, custom decoration, premium airless packaging, or another solution makes commercial sense. A concise RFQ built around these points usually produces much more useful responses than a generic request for price.

Compare the Final Three Suppliers on the Same Variables

Once I receive responses from the final three manufacturers, I compare them on the same variables rather than focusing only on unit cost. I want to know which raw material each supplier proposes, what the PDRN percentage represents, what supporting actives are included, how much customization is available, what the formula MOQ is, what the packaging MOQ is, what documents and testing are included, how long sampling will take, and what the realistic production timeline looks like. I also pay attention to the quality of the communication. A manufacturer that explains limitations, asks useful questions, and points out where packaging or claims may create problems often gives me more confidence than one that simply agrees to everything immediately. At this stage, the differences between suppliers usually become much clearer because one may be stronger in speed, another in R&D, and another in scale or documentation.

Use the Sample Stage to Confirm the Shortlist, Not Start It

I prefer to request samples only after the commercial and technical differences are already understood. The sample stage should confirm whether the formula direction, texture, fragrance, packaging, and overall product experience match the brief, not become the first time the buyer discovers that the supplier uses a different PDRN material or requires a much higher packaging MOQ than expected. For a serious project, I would normally sample from the two or three suppliers that have already shown the strongest fit on paper and then compare the physical products under the same criteria. This keeps development focused, reduces unnecessary sample fees, and makes it easier to identify which manufacturer is genuinely ready to move into bulk production.

Move From Search to Compare to Verify to Sample

The final shortlist should therefore reflect a simple but disciplined sourcing process. I begin by searching broadly enough to understand the market, then compare manufacturers based on public evidence, verify the technical and commercial details through a structured RFQ, and only then move into sampling. From our perspective at Metro Private Label, this is much more reliable than choosing a supplier because it ranks first on Google or offers the lowest initial quotation. The purpose of a shortlist is not to find the factory that says yes the fastest; it is to identify the three suppliers most likely to deliver the right formula, packaging, documentation, timeline, and production model for the buyer’s actual business.

Frequently Asked Questions About Private Label PDRN Manufacturing in China

When buyers reach the final stage of comparing PDRN manufacturers, the questions usually become much more practical. At that point, they are no longer asking whether PDRN is interesting as an ingredient; they want to know whether the project can actually fit their budget, launch schedule, packaging plan, and target market. From our perspective at Metro Private Label, these questions are often where a sourcing project becomes realistic because MOQ, concentration, documents, sampling, compliance, and packaging all need to align before a buyer should move into bulk production.

What Is the Typical MOQ for PDRN Skincare in China?

The typical MOQ for private label PDRN skincare in China depends on whether the buyer chooses a ready formula, semi-custom formula, fully custom formula, and standard or customized packaging. In practice, many conventional serums, creams, toners, and eye products using stock bottles can begin around 500 to 1,000 units per SKU, while more customized formulas commonly move into the 1,000 to 3,000-unit range. Fully customized bottles, special colors, silk-screen printing, hot stamping, or new molds can push the packaging MOQ to 3,000, 5,000, or more even when the formula itself can be produced at a lower quantity. Masks, toner pads, hydrogel products, and other special formats can follow a different MOQ structure because substrate, pouch, tray, or container suppliers have their own production minimums. For this reason, I do not treat MOQ as one factory number; I prefer to separate formula MOQ, packaging MOQ, printing MOQ, and the total finished-product quantity before deciding whether a project is commercially realistic.

Can I Start With 1,000 Units?

Yes, 1,000 units is a realistic starting quantity for many Chinese private label PDRN projects, particularly when the buyer selects an existing or semi-custom formula and uses standard packaging that is already available from the manufacturer’s supply chain. I often see this quantity work well for Amazon, Shopify, clinic, and early-stage beauty brands because it gives enough inventory to test the product without creating the cash-flow pressure of a much larger first order. The important limitation is that 1,000 units does not automatically mean every design idea is possible. A custom bottle color, complex printing process, special pump, or new mold may require a much higher component quantity, so brands launching at 1,000 units usually achieve better economics by using stock packaging and putting more of the budget into formula quality, branding, and market testing. Once sales are proven, the second or third order is usually a better time to move into more customized packaging.

Can I Customize the PDRN Concentration?

PDRN concentration can usually be customized, but I do not recommend treating concentration as a simple marketing number that should always be pushed higher. The practical range depends on the raw material being used, its concentration and specification, the amount recommended by the supplier, the surrounding formula system, the target market, and the positioning of the finished product. A buyer may request 0.5%, 1%, or another level, but the manufacturer should first clarify whether that percentage refers to the PDRN raw-material solution, Sodium DNA content, or another active basis. Increasing the addition level can also change raw-material cost, viscosity, preservation, stability, and how the product should be positioned. From our perspective, the better approach is to define the PDRN material first and then determine a concentration that makes technical and commercial sense rather than selecting the highest percentage simply because it looks stronger on a product page.

What Documents Should a PDRN Manufacturer Provide?

For an international PDRN project, I would expect the manufacturer to provide enough documentation for the buyer to understand both the raw material and the finished formula. This normally includes the full INCI list, finished-product COA, SDS or MSDS, product specification, batch information, and relevant raw-material documentation such as the PDRN or Sodium DNA COA and specification where appropriate. Depending on the product and market, the buyer may also need microbiological reports, stability information, packaging-compatibility data, Certificate of Free Sale, transportation reports, manufacturing certificates, or other supporting files. The exact document package varies from one manufacturer to another, so I prefer to confirm it before approving the formula rather than assume every document shown on the factory website is automatically included. For PDRN in particular, I would make sure the raw-material identity, concentration basis, and finished INCI remain consistent across the documents.

How Long Does PDRN Sampling Take?

A ready PDRN formula can often be sampled within several working days, while a semi-custom or fully custom project normally takes longer because the formulation team may need to change the active combination, texture, preservative system, fragrance, pH, or packaging compatibility. For a typical project, I would expect roughly one to two weeks for the first meaningful formula sample, although more complex development can require additional time and several revision rounds. The buyer should also separate formula sampling from packaging sampling because a laboratory serum can be ready long before the final decorated bottle or carton is produced. If a new formula requires longer stability observation or a new preservative strategy, the responsible manufacturer may also recommend more evaluation before bulk production. I therefore prefer suppliers that explain the sampling stages clearly rather than promise an unusually fast sample without distinguishing between a simple stock formula and a genuinely customized development project.

Can a Manufacturer Help With EU or UK Compliance?

A Chinese PDRN manufacturer can support EU or UK compliance preparation, but the factory should not be presented as replacing the legal responsibilities of the brand owner, responsible person, safety assessor, or other market-specific parties. In practice, the manufacturer can provide the full INCI, COA, SDS, specifications, manufacturing information, stability and microbiological data, packaging information, and other technical documents needed to support a CPSR, PIF, label review, and product notification process. A manufacturer with experience exporting to Europe or the UK can also help identify ingredient or claims issues earlier, which can save time during development. However, the final product still needs to meet the regulatory requirements of the destination market, and the brand should ensure that claims, labeling, safety assessment, responsible-person arrangements, and required notifications are completed correctly. From a sourcing perspective, I see the factory as the technical-documentation partner in the compliance process rather than the party that automatically makes the product legally market-ready simply by manufacturing it under ISO 22716.

Can I Use My Own Packaging?

Yes, most experienced Chinese OEM/ODM manufacturers can work with customer-supplied packaging, but I would not send components directly to the filling line without first confirming compatibility with the formula and production equipment. The manufacturer should evaluate bottle capacity, neck size, pump or dropper performance, viscosity compatibility, filling method, sealing, leakage risk, material suitability, and whether enough extra components are supplied to cover sampling, setup, quality control, and normal production loss. This is particularly important for airless bottles, droppers, unusual pumps, and premium packaging with complex internal structures. If the packaging comes from another supplier, I also want clear coordination between the packaging company and the factory because a delay or dimensional change can stop the entire production schedule. Using your own packaging can create stronger differentiation, but it only works well when the component is treated as part of the product-development process rather than as a decoration added after the formula is finalized.

Is PDRN Skincare More Expensive Than Standard Skincare?

PDRN skincare is usually more expensive than a basic hydrating or conventional private label formula, but the size of the difference depends on the raw-material specification and the rest of the project. The PDRN-related ingredient itself can increase cost, particularly when the buyer wants a better-documented source, higher addition level, or a more specialized specification, and the formula often includes additional premium actives such as peptides, ectoin, ceramides, collagen-related ingredients, or multiple forms of hyaluronic acid. Many PDRN brands also choose more premium packaging, airless pumps, individual cartons, and additional testing because the product is positioned at a higher retail price. At the same time, PDRN does not automatically make a product extremely expensive; a ready formula in stock packaging at a reasonable production quantity can still be commercially accessible. I therefore look at the complete cost structure rather than treating PDRN as a fixed surcharge. The real price difference comes from the raw material, formula complexity, packaging, testing, documentation, and order quantity working together.